N.B: Marks distribution are shown in the margin. Answer any four questions from 1-5 and answer questions 6 & 7 (compulsory). Use separate answer script for Group A and Group B. 1. (a) Mention the functions of the kidney. (b) List the renal function tests. What is renal threshold? 2+1 2. (a) How water is reabsorbed from different segments of renal tubule? What is obligatory urine volume? 2 2+1 (b) Mention the prerequisite for formation of concentrated urine. What is urea recirculation? 1+1 3. (a) State the pathway of micturition reflex. Write down the role of higher center on micturition. 1.5+1 (b) What do you mean by atonic bladder? Mention its reasons? 1.5+1 4. (a) Name the hormones affecting calcium homeostasis. 1.5 (b) Mention the functions of parathyroid hormone. What is tetany? 2.5+1 2 5. (a) Name the phases of ovarian cycle with their regulating hormones. (b) What is ovulation? Enumerate the indicators of ovulation. 1+2 6. A 38 years old female patient came to OPD with complaints of weight loss despite good appetite, palpitation, heat intolerance and protrusion of the eyeball. (a) What is the probable diagnosis for these symptoms? (b) What are the other symptoms you may find in this patient? (c) Write down the mechanism of heat intolerance and protrusion of the eyeball. 7. (a) Mention the types of cells found in the testis with their function. (b) Write down the steps of spermatogenesis. (c) Briefly state the roles of different hormones on spermatogenesis. 2.5 2.5 (d) Mention the normal sperm count. How sperm count can affect male fertility? OR (a) Name the hormones of the islets of Langerhans of pancreas. 1+2 2 2 3 3 (b) State the mechanism of action of insulin. (c) What are the functions of insulin? (d) State the consequence of insulin deficiency. 1 1 2 2 2

Answer both

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
All questions have been answered comprehensively. Here's a quick navigation guide:

Summary of Answers Covered:
QuestionTopicStatus
Q1Kidney functions; Renal function tests; Renal threshold
Q2Water reabsorption (PCT 65%, descending loop 15%, collecting duct 8–10%); Obligatory urine volume (500 mL/day); Concentrated urine prerequisites; Urea recirculation
Q3Micturition reflex (spino-bulbo-spinal, S2–S4, PMC); Higher center role; Atonic bladder (causes: sacral cord injury, tabes dorsalis, DM neuropathy, cauda equina)
Q4Calcium hormones (PTH, Calcitriol, Calcitonin); PTH functions (bone/kidney/GI); Tetany (Chvostek's, Trousseau's signs)
Q5Ovarian cycle phases (Follicular/FSH, Ovulation/LH surge, Luteal/Progesterone); Ovulation indicators (BBT rise, LH surge, progesterone, Mittelschmerz, cervical mucus, U/S)
Q6Graves' disease diagnosis; Full symptom list; Heat intolerance (T₃ ↑ BMR/Na-K-ATPase); Exophthalmos (TRAb → orbital fibroblast activation → GAG accumulation → retro-orbital edema)
Q7ATestis cells (Sertoli, Leydig, spermatogonia); Spermatogenesis steps; Hormonal roles; Normal sperm count (≥16M/mL)
Q7BIslet hormones (Insulin/β, Glucagon/α, Somatostatin/δ, PP); Insulin mechanism (tyrosine kinase → GLUT4); Insulin functions; Insulin deficiency → DKA, osmotic diuresis, wasting

Marks distribution are shown in the margin. Answer any four questions from 1-5 and answer questions 6 & 7 (compulsory). Use separate answer script for Group A and Group B. 1. (a) Define GFR. Calculate Net-filtration pressure. (b) State the factor affecting GFR. 1+2 2 2 3 2 2. (a) State reabsorption of Glucose in proximal convoluted tubule. (b) State the reabsorption of Na+ in different parts of nephron. 3. (a) Draw and label a typical nephron. (b) Give the difference between cortical and juxta-medullary nephron, Why maximum reabsorption occurs in PCT? 2+1 2 3 4. (a) List the hypothalamic releasing and inhibitory hormones. (b) Mention the clinical features of hyper secretion of growth hormone. 5. (a) Define menstruation, Write down the changes that occur in uterine endometrium during monthly female reproductive cycle. 6. 1+2 2 1 2 (b) What are the effect of estrogen and progesterone on breast? A 45 yrs. old patient come to you with the complains of polyuria, polydipsia and polyphagia- (a) What is your diagnosis? (b) What are the laboratory investigation to confirm the diagnosis? (c) Mention the complications in this case. 2 7. (a) Name the hormone secreted from thyroid gland? 1+4+2.5+2.5 (b) Illustrate the steps of synthesis of thyroid hormones? (c) What are the thyroid function test? (d) Briefly discuss about myxedema. Or (a) What are the hormones secreted from adrenal gland? (b) State the functions of Cortisol. (c) Mention the features of Cushing syndrome. (d) Mention the features of Addison's disease. 2.5+2.5+2.5+2.5

Here are comprehensive answers to all questions:

GROUP A


Question 1

(a) Definition of GFR & Calculation of Net Filtration Pressure [1+2 marks]

Glomerular Filtration Rate (GFR): GFR is defined as the volume of plasma filtered across the glomerular capillary membrane into Bowman's capsule per unit time. Normal GFR in adults is approximately 125 mL/min (180 L/day) in males and 110 mL/min in females.

Net Filtration Pressure (NFP):
NFP is determined by the balance of Starling forces across the glomerular capillary:
Forces favouring filtration (outward):
ForceValue
Glomerular capillary hydrostatic pressure (P_GC)55 mmHg
Bowman's capsule oncotic pressure (π_BC) ≈ 0 (protein-free filtrate)0 mmHg
Total favouring55 mmHg
Forces opposing filtration (inward):
ForceValue
Bowman's capsule hydrostatic pressure (P_BC)15 mmHg
Glomerular capillary oncotic pressure (π_GC)30 mmHg
Total opposing45 mmHg
Calculation:
NFP = (P_GC + π_BC) − (P_BC + π_GC) NFP = (55 + 0) − (15 + 30) NFP = 55 − 45 = +10 mmHg
A positive NFP of 10 mmHg drives filtration from glomerular capillaries into Bowman's capsule.

(b) Factors Affecting GFR [2 marks]

1. Changes in Net Filtration Pressure:
  • ↑ Glomerular capillary hydrostatic pressure (e.g., ↑ systemic BP) → ↑ GFR
  • ↑ Bowman's capsule pressure (e.g., urinary obstruction/ureteric stone) → ↓ GFR
  • ↑ Plasma oncotic pressure (e.g., dehydration, hypoproteinemia) → ↓/↑ GFR
2. Changes in Glomerular Capillary Surface Area (Kf):
  • Mesangial cell contraction (via angiotensin II, endothelin) → ↓ filtration surface area → ↓ GFR
  • Glomerulonephritis → reduced surface area → ↓ GFR
3. Afferent Arteriolar Tone:
  • Afferent arteriolar dilation → ↑ P_GC → ↑ GFR
  • Afferent arteriolar constriction (e.g., sympathetic activation, NSAIDs) → ↓ P_GC → ↓ GFR
4. Efferent Arteriolar Tone:
  • Efferent arteriolar constriction (e.g., angiotensin II) → ↑ P_GC → ↑ GFR (mild); but also ↑ oncotic pressure → net effect: maintains GFR at moderate vasoconstriction
5. Autoregulation (Intrinsic mechanisms):
  • Myogenic mechanism: ↑ BP → afferent arteriole stretches and constricts → maintains GFR
  • Tubuloglomerular feedback (TGF): ↑ NaCl at macula densa → adenosine → afferent arteriolar constriction → ↓ GFR
6. Hormonal factors:
  • Angiotensin II → constricts efferent > afferent → maintains GFR in low-flow states
  • ANP (atrial natriuretic peptide) → dilates afferent, constricts efferent → ↑ GFR
  • Prostaglandins → dilate afferent → protect GFR (important in low-flow states)
  • Norepinephrine/Epinephrine → afferent constriction → ↓ GFR

Question 2

(a) Reabsorption of Glucose in the Proximal Convoluted Tubule [2 marks]

All filtered glucose (~180 g/day) is normally completely reabsorbed in the PCT by a secondary active transport mechanism:
Mechanism:
  1. On the luminal (apical) membrane: Glucose is co-transported with Na⁺ via SGLT2 (sodium-glucose linked transporter 2) in the early PCT and SGLT1 in the late PCT
    • SGLT2: low-affinity, high-capacity (reabsorbs ~90% of filtered glucose); 1 Na⁺ : 1 glucose
    • SGLT1: high-affinity, low-capacity; 2 Na⁺ : 1 glucose
  2. Na⁺ gradient driving SGLT is maintained by Na⁺/K⁺-ATPase on the basolateral membrane (active transport — primary active)
  3. On the basolateral membrane: Glucose exits the cell into peritubular capillaries via GLUT2 (early PCT) and GLUT1 (late PCT) by facilitated diffusion
Renal Threshold & Transport Maximum:
  • Renal threshold for glucose: ~180 mg/dL plasma glucose — above this, glucose appears in urine (glucosuria)
  • Transport maximum (Tm_G): ~375 mg/min (average); maximum rate at which the tubule can reabsorb glucose
  • Above Tm: excess glucose remains in tubular fluid → osmotic diuresis

(b) Reabsorption of Na⁺ in Different Parts of the Nephron [3 marks]

Segment% of Filtered Na⁺ ReabsorbedMechanismHormonal Control
Proximal Convoluted Tubule (PCT)~65–67%Early PCT: Na⁺ co-transport with glucose, amino acids, phosphate (SGLT2, NHE3 — Na⁺/H⁺ exchanger); Late PCT: Na⁺/H⁺ exchange linked to HCO₃⁻ reabsorptionAngiotensin II ↑
Thin descending limb of loop of HenleNegligiblePassively permeable to water; little Na⁺ transport
Thick ascending limb (TAL)~25%NKCC2 (Na⁺-K⁺-2Cl⁻ cotransporter) on apical membrane; Na⁺/K⁺-ATPase basolateral; Impermeable to water — critical for countercurrentInhibited by loop diuretics (furosemide)
Distal Convoluted Tubule (DCT)~5%NCC (Na⁺-Cl⁻ cotransporter); Inhibited by thiazide diureticsAldosterone (late DCT)
Collecting Duct~3–5%ENaC (epithelial Na⁺ channel) on principal cells; Na⁺ absorbed, K⁺ secretedAldosterone (major regulator); ADH
Overall: ~99% of filtered Na⁺ is reabsorbed; only ~1% (1–5 mEq/day) excreted in urine.
Primary driving force throughout: Na⁺/K⁺-ATPase on basolateral membrane maintains low intracellular Na⁺, creating the electrochemical gradient for luminal Na⁺ entry.

Question 3

(a) Draw and Label a Typical Nephron [2 marks]

                        CORTEX
    ┌─────────────────────────────────────────┐
    │                                         │
    │   Bowman's Capsule                      │
    │       ┌──┐                              │
    │    ───┤  ├───  Glomerulus               │
    │       └──┘                              │
    │         │                               │
    │   Proximal Convoluted Tubule (PCT)       │
    │   ┌──────────────┐                      │
    │   └──────────────┘                      │
    │         │                               │
    │   Distal Convoluted Tubule (DCT)         │
    │   ┌──────────────┐                      │
    │   └──────────────┘                      │
    │         │          │                    │
    │       Connecting tubule                 │
    │         │                               │
    └─────────┼──────────────────────────────┘
              │          MEDULLA
    ┌─────────┼──────────────────────────────┐
    │         ↓                              │
    │   Loop of Henle                        │
    │      │                                 │
    │   Descending limb (thin)               │
    │      │                                 │
    │   Thin ascending limb                  │
    │      │                                 │
    │   Thick ascending limb (TAL)           │
    │      │                                 │
    │   Collecting Duct                      │
    │      │                                 │
    │      ↓                                 │
    │   Renal Pelvis → Ureter               │
    └────────────────────────────────────────┘

    Blood supply:
    Afferent arteriole → Glomerulus → Efferent arteriole
    → Peritubular capillaries / Vasa recta
Labels on a typical nephron:
  1. Renal corpuscle (Glomerulus + Bowman's capsule)
  2. Proximal convoluted tubule (PCT)
  3. Descending limb of loop of Henle
  4. Thin ascending limb of loop of Henle
  5. Thick ascending limb of loop of Henle
  6. Macula densa (at junction of TAL and DCT)
  7. Distal convoluted tubule (DCT)
  8. Connecting tubule
  9. Collecting duct
  10. Afferent arteriole, Efferent arteriole
  11. Peritubular capillaries / Vasa recta

(b) Difference Between Cortical and Juxtamedullary Nephron; Why Maximum Reabsorption Occurs in PCT [2+1 marks]

Differences Between Cortical and Juxtamedullary Nephrons:
FeatureCortical NephronJuxtamedullary Nephron
Location of glomerulusOuter/mid cortexDeep cortex, near corticomedullary junction
Proportion~85% of all nephrons~15% of all nephrons
Loop of Henle lengthShort — barely enters medullaVery long — extends deep into inner medulla
Vasa rectaPoorly developed / absentWell-developed, long vasa recta
Primary functionFiltration and reabsorptionConcentration of urine (countercurrent mechanism)
Efferent arterioleShort, forms peritubular capillariesLong, forms vasa recta
Urine concentrationLess important for concentratingCritical for producing concentrated urine

Why Maximum Reabsorption Occurs in PCT:
The PCT reabsorbs ~65–70% of filtered load because of several structural and functional advantages:
  1. Large surface area: Brush border microvilli on luminal surface amplify absorptive surface area ~20-fold
  2. High metabolic activity: PCT cells are rich in mitochondria → abundant ATP for active transport (Na⁺/K⁺-ATPase)
  3. Numerous transport proteins: Highest density of carriers (SGLT2, NHE3, Na-phosphate, Na-amino acid cotransporters)
  4. Freely permeable to water: AQP1 channels allow water to follow solute reabsorption iso-osmotically
  5. Bulk reabsorption: Na⁺, Cl⁻, K⁺, HCO₃⁻, glucose, amino acids, water — all reabsorbed together
  6. Favorable peritubular forces: Low oncotic pressure and high hydrostatic pressure in peritubular capillaries favor fluid reabsorption into capillaries
  7. No regulatory constraints: Reabsorption is obligatory and not subject to hormonal regulation (unlike DCT/collecting duct), ensuring maximum baseline reabsorption

Question 4

(a) Hypothalamic Releasing and Inhibitory Hormones [2 marks]

Releasing Hormones:
HormoneAbbreviationStimulates Pituitary to Release
Thyrotropin-releasing hormoneTRHTSH, Prolactin
Gonadotropin-releasing hormoneGnRH (LHRH)LH, FSH
Growth hormone-releasing hormoneGHRHGH
Corticotropin-releasing hormoneCRHACTH
Prolactin-releasing hormonePRHProlactin
Melanocyte-stimulating hormone-releasing hormoneMRHMSH
Inhibitory Hormones:
HormoneAbbreviationInhibits Pituitary Release of
Somatostatin (GH-inhibiting hormone)GHIH / SSGH, TSH
Dopamine (Prolactin-inhibiting hormone)PIHProlactin
Melanocyte-stimulating hormone-inhibiting hormoneMIHMSH
All hypothalamic hormones are secreted in a pulsatile manner and travel via the hypothalamo-hypophyseal portal system to the anterior pituitary.

(b) Clinical Features of Hypersecretion of Growth Hormone [2 marks]

Hypersecretion of GH causes Gigantism (if before epiphyseal fusion) or Acromegaly (if after epiphyseal fusion in adults). Most cases are due to a GH-secreting pituitary adenoma.
Features of Acromegaly (Adult hypersecretion):
Facial/Head:
  • Coarsening of facial features
  • Prognathism (protrusion of jaw), malocclusion of teeth
  • Macroglossia (enlarged tongue)
  • Prominent supraorbital ridges
  • Enlarged nose, lips, ears
  • Frontal bossing
Hands & Feet:
  • Acral enlargement — large spade-like hands, broad feet
  • Patient notices increasing ring/glove/shoe size
  • Carpal tunnel syndrome (nerve compression)
Skin & Soft Tissue:
  • Excessive sweating (hyperhidrosis) — common early symptom
  • Skin thickening, skin tags, oily skin
  • Deepening of voice
Skeletal:
  • In children (Gigantism): excessive linear growth (height >7 feet)
  • In adults: no increase in height but bone thickening
Metabolic:
  • Insulin resistance → diabetes mellitus (secondary)
  • Hypertension
  • Hypercalciuria, renal stones
Cardiovascular:
  • Cardiomegaly, cardiomyopathy → heart failure
  • Hypertension
Neurological/Pressure effects:
  • Headache (from pituitary tumour)
  • Bitemporal hemianopia (compression of optic chiasma)
  • Hypopituitarism (compression of normal pituitary)
Visceral organomegaly:
  • Hepatomegaly, splenomegaly, renomegaly
  • Goitre

Question 5

(a) Menstruation & Uterine Endometrial Changes During Monthly Female Reproductive Cycle [1+2 marks]

Definition of Menstruation: Menstruation is the periodic, cyclic shedding of the functionalis layer of the uterine endometrium accompanied by bleeding, occurring when implantation of a fertilized ovum does not take place, due to the withdrawal of estrogen and progesterone following corpus luteum degeneration. It occurs approximately every 28 days and lasts 3–7 days with a blood loss of ~30–80 mL.

Endometrial Changes During the Monthly Cycle:
Phase 1: Menstrual Phase (Days 1–5)
  • Withdrawal of progesterone and estrogen → vasoconstriction of spiral arteries → ischemia → necrosis of functionalis layer
  • Shedding of endometrial functionalis, blood, mucus, and cellular debris
  • Endometrium reduced to thin basalis layer (~1 mm)
Phase 2: Proliferative (Follicular/Estrogenic) Phase (Days 6–13)
  • Rising estrogen from developing follicles stimulates endometrial regeneration
  • Rapid proliferation of epithelial cells, stromal cells, and glands
  • Endometrium thickens from ~1 mm → ~3–5 mm
  • Glands are straight, narrow, tubular
  • Spiral arteries elongate
  • Peak: just before ovulation (day 13–14) — endometrium well-vascularized
Phase 3: Secretory (Luteal/Progestational) Phase (Days 15–28)
  • Progesterone (from corpus luteum) acts on estrogen-primed endometrium
  • Glands become tortuous, coiled, and secretory — filled with glycogen-rich fluid (nourishment for potential blastocyst)
  • Endometrium thickens further to 5–7 mm
  • Stromal cells enlarge (predecidual change)
  • Spiral arteries become highly coiled and tortuous
  • If no fertilization: corpus luteum degenerates → progesterone/estrogen fall → spiral artery vasoconstriction → menstruation begins (Day 28/Day 1)

(b) Effects of Estrogen and Progesterone on Breast [2 marks]

Effects of Estrogen:
  1. Stimulates growth and development of ductal system (lactiferous ducts) of the breast
  2. Promotes stromal development and fat deposition → breast enlargement at puberty
  3. Causes nipple development and pigmentation of areola
  4. Increases blood supply to breasts
  5. Stimulates prolactin receptors in breast tissue
Effects of Progesterone:
  1. Stimulates development of lobules and alveoli (secretory acini) — the milk-producing units
  2. Causes breast swelling and fullness in the luteal phase (water retention, ductal dilation)
  3. Induces premenstrual breast tenderness (mastalgia)
  4. Necessary for full lobulo-alveolar development (in conjunction with estrogen, prolactin, insulin, cortisol)
  5. Prepares breast for lactation during pregnancy
Together: Estrogen develops the ductal tree; progesterone develops the secretory lobular apparatus. Full lactation also requires prolactin, oxytocin, cortisol, and insulin.

GROUP B


Question 6 — Clinical Case: 45-year-old with Polyuria, Polydipsia, Polyphagia

(a) Diagnosis [1 mark]

Diabetes Mellitus — the classic triad of the "3 Ps":
  • Polyuria (osmotic diuresis due to glucosuria)
  • Polydipsia (dehydration from osmotic diuresis → thirst)
  • Polyphagia (cellular starvation despite hyperglycemia due to insulin deficiency/resistance)
Most likely Type 2 Diabetes Mellitus given the age (45 years).

(b) Laboratory Investigations to Confirm the Diagnosis [4 marks]

Diagnostic Tests (WHO/ADA criteria):
TestDiagnostic Value
Fasting Plasma Glucose (FPG)126 mg/dL (7.0 mmol/L) — after 8 hours fast
2-hour Plasma Glucose (OGTT)200 mg/dL (11.1 mmol/L) — 2 hours after 75g oral glucose load
Random Plasma Glucose200 mg/dL with classic symptoms
HbA1c (Glycated haemoglobin)6.5% (48 mmol/mol)
One abnormal result with symptoms, or two abnormal results on separate days, confirms diagnosis.
Additional Investigations:
InvestigationPurpose
Urine for glucose (Glucosuria)Confirms renal threshold exceeded (>180 mg/dL)
Urine for ketonesRule out DKA (Type 1/HONK)
Urine routine & microscopyAssess for proteinuria (nephropathy), infection
Serum C-peptideDifferentiates Type 1 (low) vs Type 2 (normal/high)
Fasting insulin levelAssess insulin resistance
Anti-GAD antibodies, Anti-islet cell antibodiesConfirm Type 1 DM (autoimmune)
Lipid profileAssess dyslipidemia (common in T2DM)
Renal function tests (serum creatinine, BUN, eGFR)Baseline renal function
Liver function testsNAFLD associated with T2DM
Urine microalbuminuriaEarly nephropathy screening
ECG / EchoCardiovascular baseline
HbA1cReflects glycemic control over past 2–3 months

(c) Complications of Diabetes Mellitus [2.5 marks]

Acute Complications:
  1. Diabetic Ketoacidosis (DKA) — Type 1 DM; hyperglycemia + ketoacidosis + dehydration
  2. Hyperosmolar Hyperglycaemic State (HHS/HONK) — Type 2 DM; extreme hyperglycemia (>600 mg/dL), no ketosis, altered sensorium
  3. Hypoglycemia — from excess insulin/OHA treatment
Chronic Complications:
Microvascular:
ComplicationFeatures
Diabetic RetinopathyBackground → proliferative retinopathy → vitreous haemorrhage → blindness; leading cause of blindness in adults
Diabetic NephropathyMicroalbuminuria → proteinuria → chronic kidney disease → ESRD; Kimmelstiel-Wilson nodules
Diabetic NeuropathyPeripheral (glove-and-stocking sensory loss, painful neuropathy); autonomic (gastroparesis, orthostatic hypotension, erectile dysfunction, bladder dysfunction)
Macrovascular:
ComplicationFeatures
Coronary Artery DiseaseMI, angina — leading cause of death in DM
Cerebrovascular DiseaseStroke, TIA
Peripheral Vascular DiseaseClaudication, gangrene, non-healing ulcers → amputation
Other:
  • Diabetic foot (neuropathy + PVD + infection)
  • Increased susceptibility to infections (TB, candidiasis, UTI, skin infections)
  • Cataracts and glaucoma
  • Hepatic steatosis (NAFLD)

Question 7 — Thyroid Gland

(a) Hormones Secreted from the Thyroid Gland [2.5 marks]

HormoneCell of OriginNotes
Thyroxine (T₄)Follicular cells~90% of secretion; less active; converted peripherally to T₃
Triiodothyronine (T₃)Follicular cells~10% of secretion; 3–5× more potent than T₄; active form
Reverse T₃ (rT₃)Peripheral conversionBiologically inactive
CalcitoninParafollicular (C) cellsLowers plasma calcium; inhibits osteoclast activity
T₃ and T₄ are iodinated tyrosine derivatives (amino acid-based); calcitonin is a 32-amino acid peptide.

(b) Steps of Synthesis of Thyroid Hormones [2.5 marks]

Thyroid hormone synthesis occurs in the follicular lumen (colloid), centered around the thyroglobulin (Tg) glycoprotein:
Step 1 — Iodide Trapping (Active Uptake):
  • Dietary iodide (I⁻) is actively transported from blood into follicular cells against a concentration gradient via Na⁺/I⁻ symporter (NIS) on the basolateral membrane
  • Driven by Na⁺/K⁺-ATPase; concentration is 20–40× plasma levels (stimulated by TSH)
Step 2 — Iodide Oxidation:
  • I⁻ is transported to the apical membrane via pendrin (Cl⁻/I⁻ exchanger)
  • At the apical membrane, thyroid peroxidase (TPO) oxidizes I⁻ → I° (active iodine/I₂), using H₂O₂ (generated by DUOX2 enzyme)
Step 3 — Organification (Iodination of Thyroglobulin):
  • TPO iodinates tyrosine residues on thyroglobulin (Tg) in the follicular lumen
  • Monoiodotyrosine (MIT) → one iodine added
  • Diiodotyrosine (DIT) → two iodines added
Step 4 — Coupling Reaction:
  • TPO catalyzes coupling of iodotyrosine residues:
    • DIT + DIT → T₄ (thyroxine) — remains bound to Tg
    • MIT + DIT → T₃ (triiodothyronine) — remains bound to Tg
  • Tg-hormone complex is stored in colloid as colloid/thyroglobulin
Step 5 — Endocytosis and Proteolysis:
  • TSH stimulates follicular cells to endocytose colloid droplets (pinocytosis)
  • Lysosomes fuse with endosomes → lysosomal proteases cleave Tg → release free T₃, T₄, MIT, DIT
Step 6 — Secretion:
  • Free T₃ and T₄ are released into the bloodstream
  • MIT and DIT are deiodinated by iodotyrosine deiodinase → iodine recycled
Step 7 — Transport in Blood:
  • 99% of T₃/T₄ bound to carrier proteins: Thyroxine-binding globulin (TBG) (major), transthyretin, albumin
  • Only free (unbound) hormone is biologically active
TSH stimulates every step of synthesis and secretion. Propylthiouracil (PTU) and carbimazole block TPO (organification and coupling). Perchlorate blocks NIS.

(c) Thyroid Function Tests [2.5 marks]

TestNormal ValueInterpretation
Serum TSH (most sensitive)0.4–4.0 mU/L↓ TSH = hyperthyroidism; ↑ TSH = hypothyroidism
Free T₄ (FT₄)0.8–1.8 ng/dL↑ in hyperthyroidism; ↓ in hypothyroidism
Free T₃ (FT₃)2.3–4.2 pg/mLElevated in T₃ toxicosis
Total T₄5–12 µg/dLAffected by binding protein levels
Total T₃80–180 ng/dLLess useful than FT₃
Radioactive iodine uptake (RAIU)5–30% at 24h↑ in Graves'; ↓ in thyroiditis
Thyroid scan (⁹⁹mTc/¹³¹I)Uniform uptakeHot nodule = autonomous; cold nodule = possible malignancy
Thyroid autoantibodiesAnti-TPO Ab, Anti-Tg Ab (Hashimoto's); TRAb/TSI (Graves')
Thyroglobulin (Tg)<55 ng/mLTumour marker for differentiated thyroid cancer post-thyroidectomy
Ultrasound thyroidStructure, nodules, vascularity
FNAC (Fine needle aspiration cytology)Diagnosis of thyroid nodules/cancer
TRH stimulation testTSH rises >2× baselineConfirms pituitary vs. hypothalamic hypothyroidism

(d) Myxedema [2.5 marks]

Definition: Myxedema is severe hypothyroidism in adults, characterized by non-pitting boggy edema due to accumulation of glycosaminoglycans (hyaluronic acid, chondroitin sulfate) in the interstitium, which attracts water but does not pit on pressure.
Cause: Usually Hashimoto's thyroiditis (autoimmune), post-thyroidectomy, radioiodine therapy, iodine deficiency, or secondary hypothyroidism (pituitary/hypothalamic failure).
Clinical Features:
SystemFeatures
GeneralWeight gain, cold intolerance, lethargy, fatigue
FacePuffy face, periorbital edema, macroglossia, loss of outer 1/3 of eyebrow (Hertoghe's sign)
SkinDry, coarse, scaly; yellowish tinge (carotenemia); non-pitting edema
Hair/NailsDry brittle hair, alopecia, brittle nails
CVSBradycardia, ↓ cardiac output, cardiomegaly, pericardial effusion, diastolic hypertension
NeurologicalSlow reflexes with delayed relaxation phase (hung-up reflexes); carpal tunnel syndrome; cerebellar ataxia; myxedema coma (severe)
PsychiatricDepression, memory impairment, "myxedema madness"
GIConstipation, ileus
ReproductiveMenorrhagia, anovulation, infertility; in males: erectile dysfunction
Metabolic↑ Cholesterol, ↑ LDL, hyponatremia
VoiceHoarse, husky voice (myxedematous infiltration of larynx)
Myxedema Coma: Life-threatening: hypothermia, cardiovascular collapse, hypoventilation, coma — precipitated by infection, cold, sedatives.
Treatment: Levothyroxine (T₄) replacement therapy.

Question 7 (OR) — Adrenal Gland

(a) Hormones from the Adrenal Gland [2.5 marks]

Adrenal Cortex (steroid hormones, from cholesterol):
ZoneHormone
Zona Glomerulosa (outermost)Mineralocorticoids — mainly Aldosterone
Zona Fasciculata (middle, largest)Glucocorticoids — mainly Cortisol; some Corticosterone
Zona Reticularis (innermost)Androgens — DHEA, DHEA-S, Androstenedione
Mnemonic: GFR (Glomerulosa → Fasciculata → Reticularis) = Salt, Sugar, Sex
Adrenal Medulla (catecholamines, from chromaffin cells):
  • Epinephrine (Adrenaline) — ~80%
  • Norepinephrine (Noradrenaline) — ~20%
  • Small amounts of Dopamine

(b) Functions of Cortisol [2.5 marks]

Cortisol is the major glucocorticoid, secreted under control of ACTH (from anterior pituitary, driven by CRH from hypothalamus). It is essential for life.
Metabolic Effects:
  1. Carbohydrate: Stimulates gluconeogenesis; inhibits peripheral glucose uptake → raises blood glucose (anti-insulin); stimulates glycogen synthesis in liver
  2. Protein: Stimulates protein catabolism in muscle, skin, bone → provides amino acids for gluconeogenesis; inhibits protein synthesis
  3. Fat: Stimulates lipolysis (free fatty acid mobilization); causes redistribution of fat (central obesity — trunk, face, neck)
Anti-inflammatory and Immunosuppressive Effects: 4. Inhibits phospholipase A₂ → ↓ arachidonic acid → ↓ prostaglandins, leukotrienes, thromboxanes 5. Inhibits NF-κB → ↓ cytokine production (IL-1, IL-2, IL-6, TNF-α) 6. Stabilizes lysosomal membranes → ↓ tissue damage 7. Reduces capillary permeability → ↓ edema 8. Inhibits T-lymphocyte proliferation and reduces eosinophil/lymphocyte counts
Cardiovascular: 9. Maintains vascular tone and responsiveness to catecholamines (permissive effect) 10. Increases cardiac output; required for normal blood pressure
Renal: 11. Mild mineralocorticoid activity → Na⁺ retention, K⁺ excretion 12. Increases GFR
Other: 13. Required for normal stress response ("fight-or-flight" sustaining hormone) 14. Permissive actions: Potentiates effects of glucagon, catecholamines, GH 15. Stimulates gastric acid secretion 16. Suppresses bone formation (inhibits osteoblasts) → osteoporosis with excess 17. Crosses placenta (fetal lung maturation — given antenatally) 18. CNS: affects mood, cognition; excess → euphoria or psychosis

(c) Features of Cushing Syndrome [2.5 marks]

Cushing syndrome = features of chronic glucocorticoid excess (endogenous or iatrogenic).
Most common cause: Iatrogenic (long-term corticosteroid therapy); endogenous: Cushing's disease (ACTH-secreting pituitary adenoma), adrenal adenoma/carcinoma, ectopic ACTH secretion.
SystemFeatures
ObesityCentral obesity — truncal obesity with thin limbs; Moon face (rounded, plethoric); Buffalo hump (dorsocervical fat pad)
SkinPurple/violaceous striae (abdominal, axillary — due to skin thinning and protein catabolism); easy bruising; thin, fragile skin; poor wound healing; acne; hirsutism
MusculoskeletalProximal myopathy (difficulty rising from chair, climbing stairs); osteoporosis → pathological fractures (vertebral, hip)
MetabolicHyperglycemia → secondary diabetes; dyslipidemia; hypokalemia (mineralocorticoid effect)
CardiovascularHypertension (common); increased risk of CVD, DVT, PE
NeuropsychiatricDepression, emotional lability, psychosis, cognitive impairment; insomnia
ReproductiveOligomenorrhea/amenorrhea; reduced libido; erectile dysfunction; hirsutism and virilization
ImmunologicalSusceptibility to infections (immunosuppression); opportunistic infections
EyesGlaucoma, cataracts (posterior subcapsular)
GrowthGrowth retardation in children

(d) Features of Addison's Disease [2.5 marks]

Addison's disease = primary adrenocortical insufficiency — destruction of adrenal cortex → deficiency of cortisol AND aldosterone (and androgens).
Causes: Autoimmune adrenalitis (most common in developed countries), TB (most common in developing countries), adrenal hemorrhage (Waterhouse-Friderichsen syndrome — meningococcemia), HIV/AIDS, metastatic cancer, fungal infections.
SystemFeatures
GeneralFatigue, weakness, lethargy, weight loss, anorexia, nausea, vomiting
CardiovascularHypotension (postural hypotension); salt craving; cardiovascular collapse in crisis
ElectrolytesHyponatremia (↓ aldosterone → Na⁺ loss); Hyperkalemia (↑ K⁺ retention); Hypoglycemia (↓ cortisol → ↓ gluconeogenesis)
Skin/MucosaHyperpigmentation — bronze discolouration of skin and mucous membranes (buccal mucosa, palmar creases, pressure areas, scars) — due to ↑ ACTH and MSH from pituitary (excess CRH → ↑ POMC → ↑ ACTH + ↑ MSH)
GIAbdominal pain, nausea, vomiting, diarrhea
NeuropsychiatricDepression, confusion, apathy
ReproductiveLoss of axillary and pubic hair (due to ↓ adrenal androgens); menstrual irregularity
Addisonian Crisis (Acute Adrenal Insufficiency):
  • Precipitated by infection, surgery, trauma, or sudden steroid withdrawal
  • Severe hypotension, shock, vomiting, abdominal pain, confusion, coma
  • Medical emergency: IV hydrocortisone + IV saline + glucose
Investigation: Low serum cortisol; low 24h urinary cortisol; ACTH stimulation test (Short Synacthen test) — cortisol fails to rise (gold standard); high plasma ACTH (primary); hyponatremia, hyperkalemia, hypoglycemia on bloods; adrenal autoantibodies (21-hydroxylase antibodies).
Treatment: Lifelong hydrocortisone (glucocorticoid replacement) + fludrocortisone (mineralocorticoid replacement); double dose during illness (sick day rules).

Answers based on Guyton & Hall Medical Physiology (14th ed.), Ganong's Review of Medical Physiology (26th ed.), and Harrison's Principles of Internal Medicine (21st ed.)

Group-B N.B: Marks distribution are shown in the margin. Answer any four questions from 8-12 and answer question 13 & 14 (compulsory). Use separate answer script for Group A and Group B. Full Marks: 20 Fill up the "T" question 8. (a) State the mechanism of inspiration and expiration. 2 (b) Mention the effect of lesion on respiration with reason: phrenic nerve, vagus nerve and lower border of medulla. 3 9. (a) Draw and label oxyhemoglobin dissociation curve. Mention significance of flat and steep part. 1.5+1 (b) Define and classify hypoxia with reasons of each. 2.5 10. (a) Write differences between action potential of SA node and ventricular muscle. 2.5 (b) Write genesis of pacemaker potential and its significance. 2.5 11. (a) Define cardiac cycle. Mention the events of cardiac cycle. 1+1.5 (b) Calculate cardiac cycle time when heart rate is 75 beats/minute. State the properties of isometric contraction period. 1+1.5 12. (a) Define end diastolic volume (EDV). Mention the factors affect EDV. 1+1.5 (b) Draw and label a normal ECG. What do the different waves of ECG represent? 1+1.5 13. (a) A patient following road traffic accident lost 3 liters of blood. He presented with hypotension, tachycardia cold clammy skin and restlessness. Explain the reason of his clinical features. 2.5 (b) Enumerate the compensatory responses activated during this condition. 2.5 14. Define blood pressure and mention its determinants. Classify blood pressure and mention normal value of each. What are the mechanisms for regulation of blood pressure? Enumerate the Renin-Angiotensin-II-Aldosterone mechanism. 2.5+2.5+2.5+2.5 Or Enumerate the neural centers for regulation of respiration with their location and function. What is inspiratory RAMP signal? Mention the chemoreceptors for regulation of respiration with their location and stimulus. What is Herring-Breuer inflation reflex? 3+2+3+2

Answer all question

Here are comprehensive answers to all questions:

GROUP B


Question 8

(a) Mechanism of Inspiration and Expiration [2 marks]

INSPIRATION (Active Process):
  1. Neural signal: Inspiratory neurons in the dorsal respiratory group (DRG) of the medulla fire → send impulses via phrenic nerve (C3, C4, C5) to diaphragm and via intercostal nerves (T1–T11) to external intercostal muscles
  2. Muscle contraction:
    • Diaphragm contracts → flattens and descends (~1.5 cm quiet; up to 10 cm deep breathing) → increases vertical diameter of thorax
    • External intercostal muscles contract → ribs move upward and outward ("bucket handle" movement) → increases anteroposterior and transverse diameters
  3. Thoracic volume increases → intrapleural pressure falls (from –5 to –8 cmH₂O)
  4. Lungs expand (elastic recoil opposes this) → intrapulmonary (alveolar) pressure falls below atmospheric (~–1 to –3 cmH₂O)
  5. Air flows in down the pressure gradient (atmosphere → alveoli) until pressures equalize
Accessory muscles during forced inspiration: Sternocleidomastoid, scalene, pectoralis minor

EXPIRATION (Passive during quiet breathing; Active during forced breathing):
Quiet Expiration:
  1. Inspiratory neurons stop firing → diaphragm and external intercostals relax
  2. Elastic recoil of lungs and chest wall → thoracic volume decreases
  3. Intrapleural pressure rises back to –5 cmH₂O; alveolar pressure rises to +1 to +3 cmH₂O (above atmosphere)
  4. Air flows out down the pressure gradient (alveoli → atmosphere)
  5. No muscle contraction required — entirely passive
Forced Expiration (Active):
  • Internal intercostal muscles contract → depress ribs → reduce thoracic volume
  • Abdominal muscles (rectus abdominis, external oblique) contract → push diaphragm upward
  • Alveolar pressure rises higher → faster airflow out

(b) Effect of Lesion on Respiration [3 marks]

1. Phrenic Nerve Lesion (C3, C4, C5):
  • The phrenic nerve supplies the diaphragm, which contributes ~70% of quiet tidal volume
  • Unilateral lesion: Paralysis of ipsilateral hemidiaphragm → paradoxical movement (rises on inspiration due to negative intrathoracic pressure from contralateral side) → reduced but not absent breathing (compensated by intercostals)
  • Bilateral lesion: Complete diaphragmatic paralysis → severe respiratory insufficiency → respiratory failure; patient dependent on accessory muscles only
  • Reason: Diaphragm is the primary muscle of inspiration; its paralysis drastically reduces tidal volume
2. Vagus Nerve Lesion:
  • Vagus carries afferent fibers from pulmonary stretch receptors (Hering-Breuer reflex)
  • Bilateral vagotomy: Eliminates the Hering-Breuer inflation reflex → inspiratory neurons not switched off at end of inspiration → breaths become deeper and slower (prolonged inspiration, increased tidal volume)
  • Also disrupts irritant receptors and J-receptors → impaired cough reflex, impaired response to pulmonary congestion
  • Reason: Vagus carries inhibitory feedback from lung stretch receptors that normally terminate inspiration; without it, inspiration is prolonged
3. Lesion at the Lower Border of Medulla (Section below Medulla):
  • Disconnects all supraspinal respiratory control from spinal motor neurons
  • Breathing ceases completelyapnea and death
  • Reason: The essential respiratory rhythm generators (DRG and VRG — pre-Bötzinger complex) are located in the medulla. Severing below medulla removes all descending respiratory drive to phrenic and intercostal motor neurons. The spinal cord alone cannot generate rhythmic breathing.

Question 9

(a) Oxyhemoglobin Dissociation Curve — Draw, Label & Significance of Flat and Steep Parts [1.5+1 marks]

The Curve:
100|──────────────╗
   |             ╗ ╚═╗  ← FLAT PART (60–100 mmHg)
 % |            ╝    ╚╗
Hb |           ╝      ╚╗
Sat|          ╝         ╚╗
   |        ╝             ╚╗
 50|       ╝                ╚╗ ← STEEP PART (10–60 mmHg)
   |      ╝                   ╚╗
   |    ╝                       ╚╗
   |  ╝                           ╚
  0|──────────────────────────────────
   0    20    40    60    80   100
         PO₂ (mmHg)

Key Points:
• P₅₀ = 26.6 mmHg (PO₂ at which Hb is 50% saturated)
• Arterial blood: PO₂ ~100 mmHg → SaO₂ ~98%
• Venous blood: PO₂ ~40 mmHg → SvO₂ ~75%
• Oxygen loading: lungs (flat part)
• Oxygen unloading: tissues (steep part)
Significance of the FLAT Part (60–100 mmHg):
  • Corresponds to oxygen loading in the lungs
  • Even if PO₂ falls from 100 → 60 mmHg (e.g., high altitude, mild lung disease), saturation only falls from 98% → 90% → Hb remains well-saturated → acts as a safety buffer
  • Ensures adequate O₂ loading despite moderate drops in alveolar PO₂
Significance of the STEEP Part (10–60 mmHg):
  • Corresponds to oxygen unloading in the tissues
  • A small drop in tissue PO₂ (from 40 → 20 mmHg) causes a large release of O₂ from Hb
  • Facilitates efficient O₂ delivery to metabolically active tissues
  • During exercise (↑ CO₂, ↓ pH, ↑ temperature, ↑ 2,3-DPG) → Bohr effect shifts curve rightward → even more O₂ unloaded

(b) Definition and Classification of Hypoxia [2.5 marks]

Definition: Hypoxia is a condition in which there is insufficient oxygen delivery to or utilization by the tissues to meet metabolic demands, despite adequate or inadequate arterial oxygen content.
Classification (4 Types):
1. Hypoxic Hypoxia (Arterial/Respiratory Hypoxia)
  • PaO₂ is reduced → low arterial O₂ saturation
  • Reasons:
    • Low atmospheric PO₂ (high altitude)
    • Hypoventilation (opiate overdose, respiratory muscle paralysis, COPD)
    • Ventilation-perfusion (V/Q) mismatch (pneumonia, pulmonary embolism, asthma)
    • Diffusion impairment (pulmonary fibrosis, ARDS)
    • Right-to-left cardiac shunt (congenital heart disease)
2. Anaemic Hypoxia (Hypemic Hypoxia)
  • Normal PaO₂ but reduced O₂ carrying capacity of blood
  • Reasons:
    • Anaemia (low Hb — iron deficiency, aplastic anaemia)
    • Carbon monoxide poisoning (CO displaces O₂ from Hb; forms carboxyhaemoglobin)
    • Methaemoglobinaemia (Fe²⁺ oxidized to Fe³⁺ — cannot carry O₂)
    • Haemoglobinopathies (sickle cell, thalassaemia)
3. Stagnant (Ischaemic/Circulatory) Hypoxia
  • Normal PaO₂ and Hb, but inadequate blood flow to tissues
  • Reasons:
    • Heart failure (↓ cardiac output)
    • Shock (hypovolaemic, septic, cardiogenic)
    • Local ischaemia (atherosclerosis, arterial obstruction, venous stasis)
4. Histotoxic Hypoxia
  • Normal PaO₂, Hb, and blood flow, but cells cannot utilize O₂
  • Reasons:
    • Cyanide poisoning (inhibits cytochrome c oxidase — complex IV of electron transport chain)
    • Carbon monoxide (also histotoxic at cellular level)
    • Severe sepsis (mitochondrial dysfunction)
Additional: Some texts include Demand hypoxia — when O₂ consumption exceeds even normal supply (e.g., extreme exercise, hyperthyroidism).

Question 10

(a) Differences Between Action Potential of SA Node and Ventricular Muscle [2.5 marks]

FeatureSA NodeVentricular Muscle
Resting membrane potentialUnstable; –60 to –70 mV (automatically depolarizes)Stable; –85 to –90 mV
Spontaneous depolarizationYes — automatic/pacemaker potential present (Phase 4 is sloped)No — remains at resting potential until stimulated
Phase 4 (Diastolic depolarization)Slow, spontaneous depolarization due to If (funny current — Na⁺/K⁺ inward), ↓ IK, ↑ ICa-TFlat isoelectric line — no spontaneous change
Upstroke (Phase 0)Slow, mediated by L-type Ca²⁺ channels (slow response)Rapid, mediated by fast Na⁺ channels (fast response)
Rate of rise (dV/dt)Slow (~1–10 V/s)Rapid (~200–1000 V/s)
OvershootMinimal or absentPresent (~+30 mV)
Phase 1 (Early repolarization)AbsentPresent (transient K⁺ outward current, Ito)
Phase 2 (Plateau)AbsentPresent (Ca²⁺ inward via L-type; K⁺ outward)
Phase 3 (Repolarization)Mediated by K⁺ efflux (IKr, IKs)Mediated by K⁺ efflux; more rapid
Action potential duration~100–150 ms~200–400 ms
Channels responsible for upstrokeVoltage-gated L-type Ca²⁺ channelsVoltage-gated fast Na⁺ channels
Blocked byVerapamil, diltiazem (Ca²⁺ blockers)Lidocaine, flecainide (Na⁺ blockers)
Intrinsic rate60–100 bpm (dominant pacemaker)20–40 bpm (latent pacemaker only)
Absolute refractory periodRelatively shortLong (prevents tetany of heart)

(b) Genesis of Pacemaker Potential and Its Significance [2.5 marks]

Genesis of Pacemaker Potential (Spontaneous Diastolic Depolarization — Phase 4):
The SA node membrane potential does not remain stable after repolarization. It spontaneously and progressively depolarizes from –60 mV until it reaches threshold (–40 mV), triggering the next action potential. This is due to three overlapping ionic mechanisms:
1. If ("Funny" Current — HCN channels) [Most important]:
  • After repolarization, membrane potential is negative → HCN (Hyperpolarization-activated Cyclic Nucleotide-gated) channels open
  • Allow slow inward current of Na⁺ (and some K⁺) → progressive depolarization
  • Called "funny" because activated by hyperpolarization (opposite to normal channels)
  • Modulated by cAMP: Sympathetic stimulation ↑ cAMP → ↑ If → faster depolarization (↑ HR); Parasympathetic ↓ cAMP → ↓ If → slower HR
2. Decay of IK (K⁺ outward current):
  • K⁺ channels (IKr, IKs) that repolarized the cell gradually close → ↓ outward K⁺ current → net inward current increases → depolarization proceeds
3. ICa-T (T-type Ca²⁺ current):
  • As membrane reaches ~–50 mV, T-type (transient) Ca²⁺ channels open → inward Ca²⁺ current → accelerates the final phase of depolarization toward threshold
  • At threshold (~–40 mV): L-type Ca²⁺ channels open → rapid upstroke of action potential
Significance of Pacemaker Potential:
  1. Automaticity: Gives the SA node its intrinsic ability to generate spontaneous rhythmic impulses without external stimulation — the basis of the heartbeat
  2. Dominant pacemaker: SA node depolarizes fastest (60–100/min) → overdrive suppresses subsidiary pacemakers (AV node 40–60/min, Purkinje 20–40/min)
  3. Rate regulation: Sympathetic (↑ slope of Phase 4 → ↑ HR) and parasympathetic (↓ slope, more negative trough → ↓ HR) directly modulate pacemaker potential — basis of autonomic HR control
  4. Clinical relevance: Sick sinus syndrome = failure of SA node pacemaker potential → bradycardia/asystole

Question 11

(a) Definition of Cardiac Cycle & Its Events [1+1.5 marks]

Definition: The cardiac cycle is the sequence of mechanical and electrical events that occur during one complete heartbeat — from the beginning of one heartbeat to the beginning of the next. It includes one period of systole (contraction/ejection) and one period of diastole (relaxation/filling). At 75 bpm, each cycle lasts 0.8 seconds.

Events of the Cardiac Cycle:
PhaseDurationEvents
Atrial systole0.1 sSA node fires; atria contract; AV valves open; ~30% additional blood pushed into ventricles (atrial kick); "a" wave of JVP; P wave on ECG
Isovolumetric contraction (IVC)0.05 sVentricles start contracting; all valves closed; ventricular pressure rises rapidly with no volume change; 1st heart sound (S1 — mitral+tricuspid closure); QRS on ECG
Rapid ejection0.11 sVentricular pressure exceeds aortic/pulmonary → semilunar valves open; rapid ejection of blood; aortic pressure rises
Reduced ejection0.14 sVentricular pressure starts to fall; continued ejection but slower; ST segment
Isovolumetric relaxation (IVR)0.08 sSemilunar valves close (S2 — aortic + pulmonary); all valves closed; pressure falls rapidly, volume constant; T wave on ECG
Rapid ventricular filling0.11 sAV valves open; blood rushes from atria into ventricles; S3 (physiological in children, pathological in adults)
Slow ventricular filling (Diastasis)0.19 sSlow continued filling; pressure equilibrates
Total: Systole = ~0.3 s; Diastole = ~0.5 s (at 75 bpm)

(b) Calculation of Cardiac Cycle Time & Properties of Isometric Contraction Period [1+1.5 marks]

Calculation:
Cardiac cycle time = 60 seconds ÷ Heart Rate = 60 ÷ 75 = 0.8 seconds (800 ms)
Breakdown at 75 bpm:
  • Atrial systole: 0.1 s
  • Ventricular systole: 0.3 s (IVC + ejection)
  • Ventricular diastole: 0.5 s (IVR + filling)

Properties of Isometric (Isovolumetric) Contraction Period:
The isovolumetric contraction (IVC) period is the phase between closure of the AV valves and opening of the semilunar (aortic/pulmonary) valves.
  1. Duration: ~0.05 seconds (50 ms)
  2. All four cardiac valves are closed simultaneously — mitral and tricuspid (just closed), aortic and pulmonary (not yet opened)
  3. Volume is constant (isovolumetric): Since no blood enters or leaves the ventricle, ventricular volume remains equal to EDV throughout this phase
  4. Pressure rises steeply: Ventricular pressure rises rapidly from ~0–8 mmHg (left ventricle) to ~80 mmHg to exceed aortic diastolic pressure
  5. Muscle fiber length does not change but tension increases — isometric contraction in mechanical terms
  6. Highest rate of pressure rise (dP/dt max): This phase has the maximum rate of pressure development — an index of myocardial contractility
  7. Energy expenditure: High ATP consumption despite no external work done (no ejection)
  8. S1 heart sound marks the beginning of this phase (AV valve closure)
  9. Correlates with the QRS complex on ECG (ventricular depolarization initiates it)

Question 12

(a) Definition of EDV & Factors Affecting EDV [1+1.5 marks]

End Diastolic Volume (EDV): EDV is the volume of blood in the ventricle at the end of diastole (just before systole begins), i.e., when the ventricle is maximally filled. Normal EDV of the left ventricle is approximately 120–130 mL (range: 100–150 mL).
EDV is also called the preload — it determines the initial stretch on cardiac muscle fibers (Frank-Starling mechanism).

Factors Affecting EDV:
Factors that INCREASE EDV (↑ preload):
  1. ↑ Venous return — most important determinant:
    • Increased blood volume (hypervolaemia, fluid overload, excess sodium retention)
    • Exercise (muscle pump, venoconstriction)
    • Lying down (gravity eliminated — more venous return)
    • Increased sympathetic venous tone (venoconstriction → ↑ venous return)
  2. Prolonged diastole (↓ Heart rate): More time for filling → ↑ EDV
  3. Increased compliance of ventricle: Ventricle fills to greater volume at lower pressure
  4. Atrial contraction (atrial kick): Contributes ~30% of final EDV
Factors that DECREASE EDV (↓ preload):
  1. ↓ Venous return:
    • Haemorrhage, dehydration (↓ blood volume)
    • Standing up (venous pooling in legs)
    • Positive pressure ventilation (impedes venous return)
  2. ↑ Heart rate (tachycardia): Less diastolic filling time → ↓ EDV
  3. Reduced ventricular compliance (ventricular hypertrophy, cardiac tamponade, constrictive pericarditis)
  4. Atrial fibrillation: Loss of atrial kick → ↓ final ventricular filling

(b) Draw and Label a Normal ECG & What Different Waves Represent [1+1.5 marks]

Normal ECG:
         R
         |
    0.5  |  ↑ ~1mV
mV   |   |
     |   |
  ──P╮   |        T╮
     ╰─Q─┴─S──────╰──────
     |   |  ST    |
     ↑   ↑  seg   ↑
     P  QRS       T

Time intervals:
• PR interval: 0.12–0.20 s
• QRS duration: 0.06–0.10 s  
• QT interval: 0.35–0.44 s
• RR interval: 0.8 s (at 75 bpm)

Amplitude:
• P wave: <0.25 mV, <0.11 s
• R wave: varies by lead (up to ~2.5 mV in V5)
• T wave: ~0.3 mV

What the Waves Represent:
Wave/IntervalElectrical EventMechanical Correlate
P waveAtrial depolarization (SA node → both atria)Atrial contraction (systole)
PR intervalTime from atrial depolarization to ventricular depolarization (includes AV nodal delay)Normal: 0.12–0.20 s; prolonged in heart block
Q waveInitial septal depolarization (left → right across septum)Beginning of ventricular contraction
QRS complexVentricular depolarization (bundle of His → bundle branches → Purkinje → ventricular myocardium)Ventricular systole (contraction) begins
ST segmentPeriod when entire ventricle is depolarized (plateau phase)Ventricular ejection; isoelectric normally; elevated in STEMI, depressed in ischaemia
T waveVentricular repolarization (epicardium repolarizes first)Ventricular relaxation begins
QT intervalTotal time of ventricular depolarization + repolarizationEntire ventricular systole; prolonged QT → risk of torsades de pointes
U waveRepolarization of Purkinje fibers (or papillary muscles)Small, sometimes visible in hypokalemia
Atrial repolarizationOccurs during QRS complex — hidden/masked by QRS

Question 13 — Clinical Case: Road Traffic Accident with 3L Blood Loss

(a) Explanation of Clinical Features [2.5 marks]

The patient has lost 3 litres of blood — approximately 60% of total blood volume (normal ~5L) → Class III–IV Haemorrhagic Shock.
1. Hypotension:
  • Massive blood loss → ↓ circulating blood volume → ↓ venous return → ↓ EDV (preload) → ↓ stroke volume (Frank-Starling) → ↓ cardiac output
  • ↓ CO → ↓ mean arterial pressure (MAP = CO × TPR)
  • Despite compensatory ↑ TPR, the volume loss is too great → BP falls
  • Result: Systolic BP <90 mmHg (hypotension)
2. Tachycardia:
  • ↓ BP → detected by baroreceptors (carotid sinus and aortic arch)
  • Baroreceptor afferents → medullary cardiovascular centre → ↓ parasympathetic (vagal) tone + ↑ sympathetic outflow
  • ↑ Sympathetic stimulation → ↑ SA node firing rate via β₁ receptorstachycardia
  • Also: ↓ venous return activates cardiopulmonary (low-pressure) receptors → further sympathetic activation
  • Tachycardia compensates by maintaining CO = HR × SV
3. Cold, Clammy Skin:
  • ↓ CO → sympathetic adrenergic activationα₁ receptor mediated cutaneous vasoconstriction
  • Blood is redirected away from skin (non-vital) to vital organs (brain, heart, kidneys) — selective vasoconstriction
  • Reduced cutaneous blood flow → skin appears pale and cold
  • Sympathetic cholinergic activation of sweat glands → sweating → skin feels clammy
  • Reason: Survival priority — vital organ perfusion over skin
4. Restlessness:
  • ↓ CO → ↓ cerebral perfusion → cerebral hypoxia
  • Cerebral hypoxia causes neurological symptoms — initially restlessness, anxiety, agitation, confusion (followed by lethargy and coma in later stages)
  • Adrenal medulla releases epinephrine (catecholamine surge) → CNS stimulation, anxiety, restlessness
  • Increased sympathetic arousal also contributes

(b) Compensatory Responses Activated [2.5 marks]

Immediate (Seconds — Neural):
  1. Baroreceptor reflex (most rapid):
    • ↓ BP → ↓ stretch of carotid/aortic baroreceptors → ↓ inhibitory afferents to vasomotor centre
    • → ↑ sympathetic outflow + ↓ parasympathetic
    • → Tachycardia, ↑ myocardial contractility, arteriolar vasoconstriction, venoconstriction
  2. Chemoreceptor activation:
    • ↓ perfusion → ↓ O₂, ↑ CO₂ → peripheral chemoreceptors (carotid/aortic bodies) stimulated
    • → ↑ sympathetic activity → ↑ vasoconstriction
  3. CNS ischaemic response (last resort, severe shock):
    • Direct ischaemia of vasomotor centre → massive sympathetic discharge → extreme vasoconstriction (MAP can rise to 250 mmHg transiently)
Short-term (Minutes — Hormonal/Fluid):
  1. Adrenal medulla activation:
    • Sympathetic stimulation → ↑ Epinephrine + Norepinephrine release → tachycardia, vasoconstriction, ↑ cardiac contractility, bronchodilation
  2. Renin-Angiotensin-Aldosterone System (RAAS):
    • ↓ renal perfusion + ↑ sympathetic stimulation of juxtaglomerular cells → ↑ Renin secretion
    • Renin → Angiotensinogen → Angiotensin I → (ACE) → Angiotensin II
    • Angiotensin II: vasoconstriction, ↑ aldosterone, ↑ ADH, ↑ thirst
    • Aldosterone → ↑ Na⁺ and water reabsorption in collecting duct → ↑ blood volume
  3. ADH (Vasopressin) release:
    • ↓ blood volume sensed by cardiopulmonary receptors + ↑ plasma osmolality → posterior pituitary releases ADH
    • ADH → ↑ water reabsorption in collecting duct; also vasoconstriction (V1 receptors)
  4. Transcapillary refill:
    • ↑ vasoconstriction → ↓ capillary hydrostatic pressure → net osmotic reabsorption of interstitial fluid into capillaries → auto-hemodilution (restores volume, dilutes Hb)
Longer-term (Hours to Days):
  1. ↑ Erythropoietin (EPO) secretion from kidneys → stimulates bone marrow → ↑ RBC production (over days–weeks)
  2. Thirst (via angiotensin II, ADH, hypothalamic osmoreceptors) → ↑ oral fluid intake
  3. Protein synthesis → restoration of plasma proteins (albumin, globulins) over days

Question 14

Definition of Blood Pressure & Its Determinants [2.5 marks]

Definition: Blood pressure (BP) is the lateral pressure exerted by the column of blood on the walls of the blood vessels per unit area. It is the force that drives blood through the circulation and is measured in millimetres of mercury (mmHg).
Determinants of Blood Pressure:
MAP = Cardiac Output (CO) × Total Peripheral Resistance (TPR) Pulse Pressure = Systolic BP − Diastolic BP
DeterminantRelationshipDetails
Cardiac Output (CO)Directly proportionalCO = HR × Stroke Volume; ↑ CO → ↑ BP
Heart Rate (HR)↑ HR → ↑ CO → ↑ BPSympathetic stimulation, catecholamines
Stroke Volume (SV)↑ SV → ↑ BPDetermined by preload (EDV), afterload, contractility
Total Peripheral Resistance (TPR)Directly proportionalTPR = 8ηL/πr⁴; arteriolar radius is dominant factor
Arteriolar tone (radius)r⁴ relationshipSmall ↓ in radius → large ↑ in TPR → ↑ diastolic BP
Blood viscosity↑ viscosity → ↑ TPR → ↑ BPPolycythaemia, dehydration
Blood volume↑ volume → ↑ venous return → ↑ CO → ↑ BPControlled by RAAS, ADH
Arterial compliance/elasticity↓ compliance → ↑ pulse pressureAtherosclerosis, ageing
Venous return/preload↑ VR → ↑ SV (Frank-Starling) → ↑ CO → ↑ BP

Classification of Blood Pressure & Normal Values [2.5 marks]

JNC 8 / AHA 2017 Classification:
CategorySystolic (mmHg)Diastolic (mmHg)
Normal<120AND<80
Elevated (Pre-hypertension)120–129AND<80
Stage 1 Hypertension130–139OR80–89
Stage 2 Hypertension≥140OR≥90
Hypertensive Crisis>180AND/OR>120
Hypotension<90 systolicOR<60 diastolic
Normal values in clinical practice:
ParameterNormal Value
Systolic BP100–120 mmHg
Diastolic BP60–80 mmHg
Mean Arterial Pressure (MAP)70–100 mmHg [= DBP + 1/3(PP)]
Pulse Pressure40 mmHg (SBP − DBP)
Capillary BP~25 mmHg (arterial end), ~10 mmHg (venous end)
Pulmonary arterial pressure25/10 mmHg (mean ~15 mmHg)
Central venous pressure (CVP)0–8 cmH₂O

Mechanisms for Regulation of Blood Pressure [2.5 marks]

I. Short-term Regulation (Seconds to Minutes — Neural):
  1. Baroreceptor Reflex (most important rapid regulator):
    • Stretch receptors in carotid sinus (CN IX) and aortic arch (CN X)
    • ↑ BP → ↑ baroreceptor firing → NTS in medulla → ↓ sympathetic, ↑ parasympathetic → ↓ HR, ↓ contractility, vasodilation → BP falls back to normal
    • ↓ BP → opposite → tachycardia, vasoconstriction → BP restored
  2. Chemoreceptor Reflex:
    • Peripheral (carotid/aortic bodies): respond to ↓ PO₂, ↑ PCO₂, ↓ pH → ↑ sympathetic → vasoconstriction
  3. CNS Ischaemic Response:
    • Severe ↓ BP → cerebral ischaemia → massive sympathetic discharge (last resort)
  4. Venoarteriolar reflex, Cushing reflex (↑ ICP → ↑ BP)
II. Intermediate Regulation (Minutes to Hours — Hormonal):
  1. Renin-Angiotensin-Aldosterone System (RAAS) (see below)
  2. ADH (Vasopressin): ↑ water reabsorption + vasoconstriction (V1 receptors)
  3. Adrenal catecholamines: Epinephrine/Norepinephrine from medulla
  4. Natriuretic Peptides (ANP/BNP): Released with ↑ atrial stretch → vasodilation + natriuresis → ↓ BP
III. Long-term Regulation (Hours to Days — Renal):
  1. Pressure natriuresis and diuresis (most powerful long-term mechanism):
    • ↑ BP → ↑ renal perfusion → ↑ Na⁺ and water excretion → ↓ blood volume → ↓ BP
    • Steady state BP is the set point at which renal fluid output = intake
  2. RAAS (chronic volume control via aldosterone)
  3. ADH (chronic water retention)

Renin-Angiotensin-Aldosterone System (RAAS) Mechanism [2.5 marks]

Stimuli for Renin Release:
  1. ↓ Renal perfusion pressure (sensed by juxtaglomerular cells — intrarenal baroreceptors)
  2. ↑ Sympathetic stimulation of JG cells (β₁ receptors)
  3. ↓ NaCl delivery to macula densa (tubuloglomerular feedback)
  4. Hyponatraemia, hypovolaemia
The Cascade:
STIMULUS (↓ BP / ↓ blood volume / ↑ sympathetic)
            ↓
Juxtaglomerular (JG) cells of afferent arteriole
            ↓
     Secrete RENIN (protease enzyme)
            ↓
  Angiotensinogen (α-2 globulin from liver)
            ↓ [Renin cleaves]
     Angiotensin I (10 amino acids — inactive)
            ↓ [ACE — Angiotensin Converting Enzyme]
              (lungs — mainly; also kidney, endothelium)
     Angiotensin II (8 amino acids — ACTIVE)
            ↓
   ┌─────────────────────────────────────┐
   │                                     │
   ▼                                     ▼
Adrenal cortex               Vascular smooth muscle
(Zona Glomerulosa)           AT1 receptors
   ↓                                     ↓
Aldosterone                      Vasoconstriction
   ↓                             ↑ TPR → ↑ BP
Collecting duct:
↑ ENaC expression
↑ Na⁺/K⁺-ATPase
→ Na⁺ + H₂O retention
→ K⁺ + H⁺ excretion
→ ↑ Blood volume → ↑ BP
Actions of Angiotensin II:
TargetEffectResult
Adrenal cortex↑ Aldosterone secretionNa⁺/H₂O retention → ↑ blood volume
Vascular smooth muscleVasoconstriction (AT1)↑ TPR → ↑ BP
Posterior pituitary↑ ADH release↑ water retention
Hypothalamus↑ Thirst (dipsogenic)↑ water intake
Kidney (PCT)↑ Na⁺/H⁺ exchanger↑ Na⁺ reabsorption directly
Sympathetic terminals↑ norepinephrine release↑ cardiac output
Cardiac/vascularHypertrophy and remodellingLong-term structural changes
Negative Feedback: ↑ BP → ↓ renin secretion; Angiotensin II directly inhibits further renin release (short-loop feedback).
Clinical Importance: ACE inhibitors (ramipril, enalapril) and ARBs (losartan, valsartan) block this system → used in hypertension, heart failure, CKD, post-MI.

Question 14 (OR) — Regulation of Respiration

Neural Centers for Regulation of Respiration [3 marks]

A. Medullary Respiratory Centers (Essential — rhythm generation):
1. Dorsal Respiratory Group (DRG)
  • Location: Nucleus tractus solitarius (NTS), dorsomedial medulla
  • Function: Primarily inspiratory neurons; generates basic respiratory rhythm; receives afferents from peripheral chemoreceptors (via CN IX, X) and lung stretch receptors; drives phrenic nerve (inspiration)
2. Ventral Respiratory Group (VRG)
  • Location: Nucleus ambiguus + nucleus retroambiguus, ventrolateral medulla
  • Sub-regions:
    • Pre-Bötzinger complex (rostral VRG): Respiratory rhythm generator — the pacemaker of breathing; generates rhythmic bursts even in isolation
    • Bötzinger complex: Expiratory neurons; inhibit inspiratory neurons
    • Caudal VRG: Active expiratory neurons → drive internal intercostals and abdominals (forced expiration only)
    • Rostral VRG: Inspiratory neurons for accessory muscles and upper airway
B. Pontine Respiratory Centers (Modifying):
3. Pneumotaxic Center (Pontine Respiratory Group — PRG)
  • Location: Nucleus parabrachialis and Kölliker-Fuse nucleus, upper pons
  • Function: Limits inspiration — sends inhibitory signals to DRG → switches off inspiration → determines respiratory rate and tidal volume; without it, breathing is deeper and slower (apneusis prevented)
4. Apneustic Center
  • Location: Lower pons
  • Function: Stimulates and prolongs inspiration (apneusis = prolonged inspiratory gasp if unchecked); normally inhibited by the pneumotaxic centre and vagal stretch receptor feedback
  • Lesion (with vagotomy): Apneustic breathing — prolonged gasping inspirations
C. Higher Centers:
  • Hypothalamus: Modifies breathing with emotional state, temperature (fever → ↑ RR)
  • Cerebral cortex: Voluntary control of breathing (speech, holding breath, forced hyperventilation)
  • Limbic system: Emotional influences (anxiety → hyperventilation)

Inspiratory RAMP Signal [2 marks]

Definition: The inspiratory RAMP signal is the pattern of neural firing by inspiratory neurons (mainly DRG) during inspiration. Instead of firing as a sudden burst, the signal gradually increases in intensity in a ramp-like fashion from the beginning to the end of inspiration, then abruptly ceases.
Mechanism:
  • At the start of each breath, inspiratory neuron firing begins weakly
  • Over ~2 seconds (quiet breathing), the firing rate progressively increases
  • This produces a smoothly increasing diaphragm contraction → steady lung inflation (rather than a jerky, sudden gasp)
  • At the end of inspiration, the signal is abruptly switched off ("off-switch") → passive expiration begins
Control of the "Off-Switch":
  1. Pneumotaxic center (upper pons) — primary switch-off; limits inspiratory time
  2. Pulmonary stretch receptor feedback (via vagus — Hering-Breuer reflex) — secondary switch-off when lungs sufficiently inflated
Significance:
  1. Produces smooth, controlled lung inflation — prevents sudden large pressure changes
  2. Allows precise control of tidal volume — the ramp continues until the off-switch fires
  3. Respiratory rate is controlled by: (a) how fast the ramp rises, and (b) when the off-switch fires
  4. ↑ Pneumotaxic stimulation → off-switch fires earlier → shorter inspiration → ↑ RR, ↓ tidal volume
  5. ↓ Pneumotaxic → longer ramp → deeper slower breathing

Chemoreceptors for Regulation of Respiration [3 marks]

1. Central Chemoreceptors (Most important for CO₂/pH)
FeatureDetails
LocationVentral surface of medulla (near but separate from respiratory centers); also in NTS, hypothalamus, cerebellum
Primary stimulusPCO₂ → CO₂ diffuses across blood-brain barrier → reacts with H₂O → H₂CO₃ → ↑ [H⁺] in CSF → stimulates chemoreceptors
NOT stimulated byHypoxaemia directly (O₂ cannot easily cross BBB)
Response↑ H⁺ in CSF → ↑ ventilation (↑ RR and tidal volume) → blows off CO₂ → restores pH
SensitivityHighly sensitive to CO₂/pH changes — responsible for ~70–80% of normal ventilatory drive
LagBlood-brain barrier delays response slightly; CSF has poor buffering (low protein) → very sensitive to CO₂
2. Peripheral Chemoreceptors
FeatureDetails
LocationCarotid bodies (at bifurcation of common carotid artery — CN IX afferents) and Aortic bodies (aortic arch — CN X afferents); carotid bodies are functionally dominant
Primary stimulus↓ PaO₂ (hypoxaemia) — most important peripheral stimulus; also respond to ↑ PCO₂, ↓ pH, ↓ blood flow, ↑ temperature, nicotine
Threshold for O₂Only activated when PaO₂ falls below 60 mmHg (on steep part of ODC) — explains why mild hypoxaemia has little ventilatory effect
Cell typesType I (glomus) cells — chemosensitive; Type II (sustentacular/sheath) cells — supporting
Mechanism↓ PO₂ → inhibits K⁺ channels in Type I cells → depolarization → Ca²⁺ influx → dopamine/ACh release → afferent firing
Response↑ ventilation (hypoxic ventilatory response); also cardiovascular effects (bradycardia, vasoconstriction)
SignificancePrimary oxygen sensors; important at high altitude; dominant drive when CO₂ sensitivity is blunted (COPD — "hypoxic drive")
Summary of stimuli and receptors:
StimulusReceptor
↑ PCO₂ / ↓ pH (CSF)Central chemoreceptors (dominant)
↑ PCO₂ / ↓ pH (blood)Peripheral chemoreceptors (rapid response)
↓ PaO₂ <60 mmHgPeripheral chemoreceptors only

Hering-Breuer Inflation Reflex [2 marks]

Definition: The Hering-Breuer inflation reflex is a protective reflex that terminates inspiration and initiates expiration when the lungs are inflated beyond a certain volume, thereby preventing over-inflation. Described by Hering and Breuer in 1868.
Receptor:
  • Slowly adapting pulmonary stretch receptors (SARs) — located in the smooth muscle of airways (trachea, bronchi, bronchioles)
Pathway:
  1. Lung inflation → stretch of airways → SARs activated → discharge increases progressively with inflation
  2. Afferent signals travel via myelinated fibres in the vagus nerve (CN X) to the medulla
  3. Signals reach the NTS (DRG) → activate the inspiratory off-switch (pneumotaxic centre also involved)
  4. Inhibit inspiratory neurons → inspiration terminates
  5. Expiration begins passively
In Reverse (Deflation reflex):
  • Lung deflation activates SARs (low firing) → removes inhibition from inspiratory neurons → next inspiration triggered (Hering-Breuer deflation reflex)
Significance:
  1. Sets tidal volume — prevents excessive tidal volume and over-inflation of lungs
  2. Sets respiratory rate — by switching off inspiration earlier → shorter inspiratory time → more breaths per minute
  3. Prevents pneumothorax (barotrauma) by limiting inspiratory pressure
  4. Important in newborns and during anaesthesia (tidal volumes >800 mL in adults trigger this reflex; it is more important in infants where it is active at normal tidal volumes)
  5. Vagotomy eliminates this reflex → slow, deep breathing (apneustic pattern with apneustic centre intact)
Clinical note: In adults at rest, this reflex is relatively inactive at normal tidal volumes (600 mL); becomes important during large tidal volume breaths (>1 L) or in controlled mechanical ventilation.

Answers based on Guyton & Hall Medical Physiology (14th ed.), Ganong's Review of Medical Physiology (26th ed.), West's Respiratory Physiology (10th ed.), and Berne & Levy Physiology.

Answer group A also

The original exam paper for Group A of this session wasn't included in your message. Could you please share the Group A questions so I can answer them fully?
If you're referring to the same Group A from the previous paper (the one with questions 1–7 on kidney functions, GFR, nephron, hypothalamic hormones, menstruation, diabetes, and thyroid/adrenal), those have already been answered in full in my previous response above.
Please clarify which Group A you need answered, or paste the questions here and I'll get right to it.

Sheikh Hasina Medical University, Khulna 1st Professional MBBS Examination, May-2023 Subject: Physiology (Paper 1) Subject Code: 113 Full Marks: 70 Time: 2 hours 30 Minutes Group-A N.B: Marks distribution are shown in the margin. Answer any four questions from 1-5 and answer questions 6 & 7 (compulsory). Use separate answer script for Group A and Group B. 1. (a) Define resting membrane potential. Mention its genesis. 1+1.5 (b) Draw and label action potential of a neuron. What is spike potential? 1.5+1 2. (a) Define action potential. Enumerate the differences between receptor potential and action potential. 1+1.5 (b) Draw and label structure of a cell membrane. What are the functions of cell membrane proteins? 1.5+1 3. (a) State the Landsteiner's law. Why ABO system is called classic blood group? 1.5+1 (b) State the effects of mismatch blood transfusion. Write the reason of kidney shut down. 1.5+1 4. (a) State the stimulus for secretion and functions of Cholecystokinin. 1+1.5 (b) Mention the factors regulate gastric emptying. What is law of the gut? 1.5+1 5. (a) Mention the steps and factors necessary for erythropoiesis. 1.5+1 (b) State the neural regulation of defecation reflex. 2.5 6. (a) A patient presented with pallor, weakness, fatigue and respiratory distress. His Hemoglobin level was 7 gram/dl, MCV, MCH and MCHC was decreased. Mention the probable reason of the report. 2.5 2.5 (b) Mention the significance of MCV, MCH and MCHC. 2.5+2.5+2.5+2.5 7. Classify cell membrane transport with example of each. What are the properties of primary active transport? What is the significance of Na+-K+ pump? How does Na+-K+ pump maintain cell volume? Or Define clot and mention the fate of clot. State the basic steps of coagulation. 2.5+2.5+2.5+2.5 1 Why is it called positive feedback mechanism? Why blood does not clot inside the cardiovascular system? This one answer all

Here are comprehensive answers to all Group A questions:

GROUP A

Sheikh Hasina Medical University, Khulna

1st Professional MBBS — Physiology Paper 1, May 2023


Question 1

(a) Resting Membrane Potential — Definition & Genesis [1+1.5 marks]

Definition: Resting membrane potential (RMP) is the electrical potential difference across the cell membrane of an excitable cell at rest, with the inside of the cell being electrically negative relative to the outside. It is measured in millivolts (mV).
  • Neuron: –70 mV
  • Skeletal muscle: –90 mV
  • Cardiac muscle: –85 to –90 mV
  • Smooth muscle: –50 to –60 mV

Genesis of Resting Membrane Potential:
RMP arises due to the unequal distribution of ions across the membrane and selective membrane permeability:
Ion Distribution (Concentration Gradients):
IonIntracellularExtracellular
K⁺140 mEq/L4 mEq/L
Na⁺14 mEq/L142 mEq/L
Cl⁻4 mEq/L103 mEq/L
Large anions (A⁻)65 mEq/L~0
Mechanism of RMP Generation:
  1. K⁺ leak channels (K⁺ dominates RMP):
    • At rest, membrane is 50–100× more permeable to K⁺ than Na⁺ (leak K⁺ channels are open)
    • K⁺ diffuses outward down its concentration gradient → positive charges leave → inside becomes negative
    • This creates an electrical gradient opposing further K⁺ efflux
    • Equilibrium point for K⁺ (Nernst potential) ≈ –94 mV
  2. Na⁺ leak (small inward current):
    • Small Na⁺ permeability → Na⁺ leaks inward → slightly depolarizes (makes RMP less negative than K⁺ equilibrium)
    • Nernst potential for Na⁺ ≈ +61 mV
  3. Large intracellular anions (A⁻):
    • Large negatively charged proteins and organic phosphates cannot cross the membrane → trapped inside → contribute to intracellular negativity (Gibbs-Donnan equilibrium)
  4. Na⁺-K⁺-ATPase pump (electrogenic contribution):
    • Pumps 3 Na⁺ out for every 2 K⁺ in → net export of positive charge → directly contributes approximately –3 to –4 mV to RMP (electrogenic)
    • More importantly, maintains the concentration gradients of Na⁺ and K⁺ that drive the leak currents
    • Without the pump, gradients would dissipate → RMP would collapse
Net result: The combination of K⁺ efflux, Na⁺ influx, trapped anions, and the Na⁺/K⁺ pump establishes the RMP at approximately –70 mV (inside negative).

(b) Draw and Label Action Potential of a Neuron; Spike Potential [1.5+1 marks]

Action Potential of a Neuron:
        +35|          ╭──╮  ← OVERSHOOT (Peak)
           |         /    \
           |        /      \
     mV    |       /        \
           |      /          \
        0  |─────╯            ╲────────────────
           |  ↑                \
           | Threshold          \  REPOLARIZATION
           | (~-55mV)            \      (Phase 3)
      -55  |...........           \
           |                       ╲
      -70  |════════════════════════╲══╮═══════  ← RMP
           |     RMP                   ╲     ↑
      -80  |                            ╰──╯
           |                           AFTER-HYPERPOLARIZATION
           |                           (Undershoot)
           |_____________________________________________
           0    0.5    1.0    1.5    2.0  (milliseconds)

PHASES:
0 = Upstroke/Depolarization (Na⁺ channels open) → 0 to +35mV
1 = Early repolarization (K⁺ efflux begins)
2 = Plateau (absent in neuron; present in cardiac)
3 = Repolarization (K⁺ efflux, Na⁺ channels inactivate)
4 = After-hyperpolarization (K⁺ channels slow to close)

Labels on diagram:
1. Resting membrane potential (–70 mV)
2. Threshold potential (–55 mV)
3. Depolarization (upstroke) — Phase 0
4. Overshoot/Peak (+35 mV)
5. Repolarization — Phase 3
6. After-hyperpolarization (undershoot, –80 mV)
7. Absolute refractory period (during depolarization + early repolarization)
8. Relative refractory period (during after-hyperpolarization)

Spike Potential: The spike potential is the rapid, transient all-or-none depolarization constituting the main body of an action potential — the sharp upstroke from threshold to overshoot (+35 mV) and back down to near resting potential. It lasts approximately 1 ms in a neuron and represents the combined phase of rapid Na⁺ channel opening (depolarization) and K⁺ channel opening (repolarization). It is called a "spike" because of its sharp, needle-like appearance on an oscilloscope tracing. The spike is followed by the after-potentials (after-depolarization and after-hyperpolarization). The spike obeys the all-or-none law — it either occurs fully or not at all.

Question 2

(a) Definition of Action Potential & Differences Between Receptor Potential and Action Potential [1+1.5 marks]

Definition of Action Potential: An action potential is a rapid, transient, self-propagating reversal of membrane potential in an excitable cell (neuron, muscle) in response to an adequate stimulus, during which the inside of the cell briefly becomes positive relative to the outside. It follows the all-or-none law and lasts approximately 1 ms in a neuron.

Differences Between Receptor Potential and Action Potential:
FeatureReceptor PotentialAction Potential
DefinitionGraded depolarization produced at a sensory receptor in response to a stimulusAll-or-none electrical impulse propagated along nerve/muscle membrane
NatureGraded — amplitude proportional to stimulus intensityAll-or-none — fixed amplitude regardless of stimulus strength
LocationReceptor membrane (sensory ending)Axon hillock, along axon, muscle membrane
PropagationNon-propagated (local, decays with distance — decremental)Propagated without decrement along the entire axon
AmplitudeSmall, variable (few mV to ~20 mV)Large, constant (~100–110 mV in neuron)
SummationCan summate (temporal and spatial)Cannot summate
Refractory periodNo refractory periodHas absolute and relative refractory periods
ThresholdNo threshold requiredMust reach threshold (~–55 mV) to trigger AP
Ion channelsMechanically/chemically gated channels (ligand or mechanically gated)Voltage-gated Na⁺ and K⁺ channels
FunctionEncodes stimulus intensity (frequency code), duration, and modality → triggers AP at axon hillockTransmits information along nerve to CNS/effector
RepolarizationPassive dissipation when stimulus stopsActive — K⁺ efflux via voltage-gated channels
ExampleGenerator potential in Pacinian corpuscle, end-plate potential (EPP)Nerve impulse, muscle action potential

(b) Draw and Label Cell Membrane Structure; Functions of Membrane Proteins [1.5+1 marks]

Structure of Cell Membrane (Fluid Mosaic Model — Singer & Nicolson, 1972):
EXTRACELLULAR FLUID
         │
    ─────┼────────────────────────────────────────
  ╔══════╧══════╗   Glycoprotein   Glycolipid
  ║  Peripheral ║       │              │
  ║   protein   ║   ╭──┴──╮        ╭──┴──╮
  ╚═════════════╝   │  TM │        │     │
                    │     │        │     │
    ──────────────  │     │  ──────│     │──────
   ░░░░░░░░░░░░░░░  │     │ ░░░░░░░│     │░░░░░
   ░░Phospholipid░  │     │ ░░░░░░░│     │░░░░░ ← Lipid
   ░░ Bilayer    ░  │     │ ░░░░░░░│     │░░░░░   bilayer
   ░░░░░░░░░░░░░░░  │     │ ░░░░░░░│     │░░░░░
    ──────────────  ╰──┬──╯ ──────╰──┬──╯──────
                       │             │
    ════════════════╗  │   Integral  │
    Peripheral      ║  │   (Trans-   │
    protein (inner) ╚══╝   membrane) │
                              protein│
INTRACELLULAR FLUID
         │
    ─────┼────────────────────────────────────────

Key labels:
1. Phospholipid bilayer (hydrophilic heads outside, hydrophobic tails inside)
2. Integral/transmembrane proteins (span full bilayer)
3. Peripheral proteins (attached to surface, not spanning)
4. Glycoproteins (carbohydrate chains on outer surface)
5. Glycolipids (lipid + carbohydrate)
6. Cholesterol (between phospholipids — controls fluidity)
7. Hydrophilic head (phosphate group)
8. Hydrophobic tail (fatty acid chains)

Functions of Cell Membrane Proteins:
  1. Transport proteins (channels and carriers):
    • Ion channels (Na⁺, K⁺, Ca²⁺, Cl⁻) — passive transport
    • Carrier proteins (GLUT transporters) — facilitated diffusion
    • Pumps (Na⁺/K⁺-ATPase) — active transport
  2. Receptor proteins:
    • Bind hormones, neurotransmitters, growth factors
    • Examples: insulin receptor (tyrosine kinase), β-adrenergic receptor (GPCR), nicotinic ACh receptor (ligand-gated ion channel)
  3. Enzymatic proteins:
    • Catalyze reactions at membrane surface
    • Examples: adenylyl cyclase (produces cAMP), ACE (angiotensin converting enzyme), Na⁺/K⁺-ATPase
  4. Structural/Anchoring proteins:
    • Link membrane to cytoskeleton (spectrin, ankyrin in RBCs)
    • Maintain cell shape and membrane integrity
  5. Cell adhesion molecules (CAMs):
    • Attach cells to each other or extracellular matrix
    • Examples: integrins, cadherins, selectins
  6. Identification/Antigen proteins:
    • Cell surface markers — self-recognition, immune identification
    • ABO blood group antigens, MHC (HLA) molecules
  7. Signal transduction proteins (G-proteins):
    • Transmit signals from receptor to intracellular effectors
    • Examples: Gs, Gi, Gq proteins coupling receptors to adenylyl cyclase or phospholipase C

Question 3

(a) Landsteiner's Law & Why ABO is Called Classic Blood Group [1.5+1 marks]

Landsteiner's Law: Landsteiner's law states that:
  1. "If an agglutinogen (antigen) is present on the red blood cells, the corresponding agglutinin (antibody) is absent in the plasma."
  2. "If an agglutinogen is absent from the red blood cells, the corresponding agglutinin is always present in the plasma."
In other words: antigen and its corresponding antibody never coexist in the same individual (as this would cause auto-agglutination).
Blood GroupAntigen on RBCAntibody in Plasma
AA antigenAnti-B
BB antigenAnti-A
ABA and B antigensNone
ONoneAnti-A and Anti-B

Why ABO System is Called the Classic Blood Group:
  1. First blood group discovered — Karl Landsteiner described it in 1901 (Nobel Prize 1930) — the original/classic system
  2. Universal clinical importance — most significant for blood transfusion compatibility; mismatched transfusion is potentially fatal
  3. Naturally occurring antibodies (isohemagglutinins) — Anti-A and Anti-B antibodies are present without prior sensitization (exposure to foreign blood) — unlike other blood group antibodies that require sensitization; these arise from exposure to environmental antigens (food, bacteria) with similar structures
  4. Landsteiner's law applies strictly — the reciprocal antigen-antibody relationship is absolute in ABO
  5. Template for all other blood group systems — established the fundamental principles (antigens, antibodies, compatibility testing) used for all subsequent blood group discoveries (Rh, Kell, Duffy, Kidd, etc.)
  6. Genetic determination — ABO antigens are controlled by a single gene locus on chromosome 9 with three alleles (I^A, I^B, i) — a model for co-dominant inheritance
  7. Tissue expression — ABO antigens are expressed not just on RBCs but also on platelets, vascular endothelium, epithelial cells, and secretions — making them important beyond just transfusion medicine

(b) Effects of Mismatched Blood Transfusion & Reason for Kidney Shutdown [1.5+1 marks]

Effects of Mismatched Blood Transfusion (Acute Haemolytic Transfusion Reaction):
Immediate (within minutes):
  1. Agglutination — donor RBCs clump due to recipient's antibodies binding donor antigens → clumps block capillaries
  2. Intravascular haemolysis — complement activation (classical pathway) → membrane attack complex (MAC) → lysis of donor RBCs → release of haemoglobin, haem, and RBC debris into plasma
  3. Haemoglobinaemia — free Hb in plasma → haemoglobinuria (red/brown urine)
Systemic Effects: 4. Fever, chills, rigors — pyrogens from lysed RBCs 5. Hypotension and shock — antigen-antibody complexes activate complement → anaphylatoxins (C3a, C5a) → mast cell degranulation → histamine release → vasodilation + ↑ capillary permeability → distributive shock 6. Back and loin pain — kidney ischaemia, renal capsule distension 7. Disseminated Intravascular Coagulation (DIC) — RBC stroma activates clotting cascade → widespread clotting + consumption of clotting factors → paradoxical bleeding 8. Jaundice — haemolysis → ↑ unconjugated bilirubin 9. Acute kidney injury (Renal shutdown) — see below 10. Death — in severe untreated cases

Reason for Kidney Shutdown (Acute Renal Failure):
Multiple mechanisms converge:
  1. Haemoglobin precipitation in renal tubules:
    • Free plasma Hb filtered at glomerulus → in acidic tubular fluid → precipitates as acid haematin crystals → physically blocks renal tubules (tubular obstruction) → back-pressure → ↓ GFR
  2. Renal vasoconstriction:
    • Complement-mediated (C3a, C5a) and antigen-antibody complexes → reflex renal arteriolar vasoconstriction → ischaemia of renal cortex → acute tubular necrosis (ATN)
    • ↓ renal blood flow → ↓ GFR → oliguria/anuria
  3. Haemoglobin toxicity:
    • Free Hb is directly nephrotoxic to proximal tubular cells → oxidative injury → tubular cell necrosis
    • Free Hb scavenges nitric oxide → renal vasoconstriction
  4. DIC:
    • Microthrombi in glomerular capillaries → ↓ filtration surface → ↓ GFR
    • Bilateral renal cortical necrosis in severe DIC
  5. Shock-induced renal ischaemia:
    • Systemic hypotension → ↓ renal perfusion pressure → prerenal component → compounding tubular injury

Question 4

(a) Stimulus for Secretion and Functions of Cholecystokinin (CCK) [1+1.5 marks]

Stimulus for Secretion of CCK: CCK is secreted by I-cells of the duodenum and upper jejunum mucosa in response to:
  1. Fatty acids and monoglycerides in the duodenum — most potent stimulus (products of fat digestion)
  2. Proteins and amino acids (especially phenylalanine, tryptophan, methionine) in duodenum
  3. Gastric acid entering duodenum (minor stimulus)
  4. Distension of the duodenum (minor)
  5. Vagal stimulation (cholinergic — minor)
Carbohydrates do NOT stimulate CCK secretion.

Functions of CCK:
  1. Gallbladder contraction — contracts gallbladder smooth muscle → expels bile into duodenum (most important action; CCK = "gallbladder-contracting hormone")
  2. Relaxation of sphincter of Oddi — allows bile and pancreatic juice to flow into duodenum
  3. Pancreatic enzyme secretion — stimulates acinar cells → secretion of digestive enzymes (lipase, amylase, proteases) — acts synergistically with secretin
  4. Inhibition of gastric emptying — contracts pyloric sphincter + inhibits antral motility → slows delivery of chyme into duodenum (allows time for digestion)
  5. Augments secretin action — potentiates secretin's stimulation of pancreatic HCO₃⁻ secretion
  6. Trophic effect on pancreas — promotes growth and maintenance of pancreatic acinar cells
  7. Satiety signal — acts on hypothalamus (via vagal afferents and circulation) → suppresses appetite → reduces food intake
  8. Stimulates intestinal motility — increases segmentation in small intestine

(b) Factors Regulating Gastric Emptying & Law of the Gut [1.5+1 marks]

Factors Regulating Gastric Emptying:
Factors that ACCELERATE Gastric Emptying:
  1. Large volume of gastric content (distension) → ↑ gastric peristalsis
  2. Liquid meals empty faster than solid
  3. Isotonic solutions empty faster than hyper/hypotonic
  4. Carbohydrates empty fastest; then proteins; fats slowest
  5. Gastrin (minor) — increases antral peristalsis
  6. Motilin — increases gastric motor activity (interdigestive)
  7. Erect posture (gravity aids)
Factors that INHIBIT Gastric Emptying (Enterogastric Reflex + Enterogastrones):
  1. Fat in duodenum — most powerful inhibitor; via CCK + neural reflex
  2. Acid (↓ pH) in duodenum — triggers secretin release → inhibits gastric motility
  3. Hyperosmolar solutions in duodenum — osmoreceptors trigger inhibitory reflex
  4. Distension of duodenum — stretch receptors → enterogastric reflex (via vagus and intrinsic plexus)
  5. Pain, fear, anxiety — sympathetic activation → inhibits gastric motility
  6. CCK, Secretin, GIP (Gastric Inhibitory Peptide / GIP) — hormonal inhibition
  7. Fatty acids, amino acids in duodenum → enterogastrones
  8. Drugs: Anticholinergics, opioids (delay emptying)

Law of the Gut (Bayliss and Starling, 1899): The law of the gut (also called the myenteric reflex or peristaltic reflex) states:
"Local distension of the gut causes contraction above (oral/proximal to) and relaxation below (aboral/distal to) the point of stimulation, resulting in propulsion of contents along the gut."
Mechanism:
  1. Bolus of food distends the gut wall
  2. Sensory (afferent) neurons of Meissner's (submucosal) plexus detect distension
  3. Ascending (oral) limb: Interneurons activate excitatory motor neurons → release ACh and substance P → circular muscle contracts → propulsion
  4. Descending (aboral) limb: Interneurons activate inhibitory motor neurons → release NO, VIP, ATP → circular muscle relaxes → receptive relaxation
  5. Longitudinal muscle contraction above and relaxation below further aids propulsion
This law is the physiological basis of peristalsis throughout the entire GI tract.

Question 5

(a) Steps and Factors Necessary for Erythropoiesis [1.5+1 marks]

Steps of Erythropoiesis:
Erythropoiesis occurs in red bone marrow (in adults: vertebrae, sternum, ribs, iliac crest, proximal femur/humerus). Each step involves progressive reduction in cell size, loss of nucleus, and Hb accumulation:
Pluripotent Haematopoietic Stem Cell (PHSC)
        ↓
Common Myeloid Progenitor (CMP)
        ↓
BFU-E (Burst Forming Unit — Erythroid)
        ↓
CFU-E (Colony Forming Unit — Erythroid)
        ↓
PROERYTHROBLAST (Pronormoblast)
    — Largest cell; large nucleus; basophilic cytoplasm; no Hb yet
        ↓
BASOPHILIC ERYTHROBLAST (Early normoblast)
    — Active ribosome synthesis; cytoplasm deeply basophilic; begins Hb synthesis
        ↓
POLYCHROMATOPHILIC ERYTHROBLAST (Intermediate normoblast)
    — ↑ Hb; cytoplasm mixed pink-blue (polychromatic); nucleus shrinking
        ↓
ORTHOCHROMATIC ERYTHROBLAST (Late normoblast)
    — Cytoplasm nearly pink (Hb-rich); nucleus pyknotic (dark, condensed)
        ↓ (nuclear extrusion)
RETICULOCYTE
    — Anucleate; contains residual ribosomal RNA (basophilic stippling on supravital stain)
    — Released into blood; matures in 1–2 days in circulation
        ↓
MATURE ERYTHROCYTE (RBC)
    — Biconcave disc, 7.2 µm; no nucleus/organelles; full Hb content (~34g/dL)
Duration: ~5–7 days in marrow; reticulocyte stage 1–2 days in blood.

Factors Necessary for Erythropoiesis:
FactorRole
Erythropoietin (EPO)Primary hormonal stimulus; secreted by peritubular cells of kidney in response to hypoxia; drives CFU-E proliferation and differentiation
Iron (Fe²⁺)Essential component of haem (Fe²⁺ + protoporphyrin IX = haem); deficiency → microcytic hypochromic anaemia
Vitamin B₁₂ (Cobalamin)Required for DNA synthesis (via thymidine synthesis); deficiency → megaloblastic anaemia
Folic acid (Folate)Required for DNA synthesis (tetrahydrofolate → thymidylate); deficiency → megaloblastic anaemia
Vitamin CAids iron absorption (reduces Fe³⁺ → Fe²⁺); antioxidant
Vitamin B₆ (Pyridoxine)Required for haem synthesis (ALA synthase cofactor)
CopperRequired for iron mobilization from stores (ceruloplasmin/ferroxidase)
CobaltStimulates EPO production
Proteins/Amino acidsProvide globin chains for Hb synthesis
Thyroid hormones, androgens, GHStimulate erythropoiesis (enhance EPO sensitivity)
Intrinsic factor (Castle's)Required for ileal absorption of Vit B₁₂

(b) Neural Regulation of Defecation Reflex [2.5 marks]

Defecation Reflex is a coordinated sequence of spinal, autonomic, and voluntary neural events that empty the rectum.
Normal Continence:
  • Rectum normally empty; internal anal sphincter (IAS) tonically contracted (sympathetic, L1–L2 via hypogastric nerve)
  • External anal sphincter (EAS) tonically contracted (voluntary, pudendal nerve, S2–S4)
Triggering:
  • Mass movement (peristalsis) propels faeces into rectum → rectal distension → stretch receptors activated
Intrinsic (Myenteric) Reflex:
  1. Rectal distension → myenteric plexus activated → short reflex
  2. Peristaltic waves spread down sigmoid colon and rectum
  3. Rectosphincteric reflex (RAIR): Rectal distension → IAS relaxes transiently (via NO/VIP from myenteric plexus) — allows sampling
Extrinsic Spinal Reflex:
  1. Afferent signals travel via pelvic nerves (S2–S4) to the sacral defecation center (S2–S4)
  2. Parasympathetic outflow (pelvic nerve, S2–S4):
    • Strengthens peristaltic waves in sigmoid colon and rectum
    • Further relaxation of IAS
  3. Sympathetic inhibition withdrawn (hypogastric nerve, L1–L2) → IAS relaxes further
Voluntary Component: 4. Urge to defecate perceived consciously 5. If socially appropriate: Voluntary relaxation of EAS (pudendal nerve inhibition) 6. Increased intra-abdominal pressure via Valsalva manoeuvre (diaphragm + abdominal muscle contraction, glottis closed) 7. Puborectalis relaxation → anorectal angle straightens from 90° → 130–140° → facilitates defecation
If Defecation is Postponed:
  • Voluntary contraction of EAS (pudendal nerve activation) → overrides reflex
  • Rectum accommodates (receptive relaxation) → urge subsides temporarily
Higher Centers:
  • Cerebral cortex (frontal lobe): Voluntary inhibition/facilitation via corticospinal tracts
  • Pontine defecation center: Coordinates defecation (analogous to pontine micturition center)
  • In spinal cord injury above S2: Defecation reflex intact but voluntary control lost → reflex (automatic) defecation

Question 6 — Clinical Case: Pallor, Weakness, Fatigue, Respiratory Distress; Hb 7 g/dL; MCV, MCH, MCHC decreased

(a) Probable Reason for the Report [2.5 marks]

Diagnosis: Iron Deficiency Anaemia (IDA)
The blood picture shows:
  • Hb = 7 g/dL (severely low; normal: male 13.5–17.5, female 12–15.5 g/dL) → anaemia
  • MCV decreased → microcytic RBCs (small)
  • MCH decreased → hypochromic RBCs (low Hb per cell)
  • MCHC decreased → low Hb concentration in each RBC
This pattern of microcytic, hypochromic anaemia with decreased MCV, MCH, and MCHC is the hallmark of Iron Deficiency Anaemia.
Why Iron Deficiency Causes This Pattern:
  1. Iron is essential for haem synthesis (Fe²⁺ + protoporphyrin IX → haem; 4 haem + 4 globin → Hb)
  2. In iron deficiency: insufficient haem → ↓ Hb synthesis per cell
  3. Erythroid precursors undergo extra divisions (because cytoplasmic Hb threshold for division is not reached) → smaller cells (microcytosis)
  4. Each cell contains less Hb than normal → hypochromia (pale centre >1/3 of RBC diameter on smear)
  5. ↓ Hb per cell (MCH) and ↓ Hb concentration per unit volume of cells (MCHC)
Probable Causes of IDA in this patient:
  1. Chronic blood loss — most common cause (menorrhagia in females, peptic ulcer, GI malignancy, hookworm infestation)
  2. Inadequate dietary intake — poor diet, vegetarian/vegan diet, poverty
  3. Malabsorption — coeliac disease, post-gastrectomy (↓ acid → ↓ Fe³⁺ → Fe²⁺ conversion), Crohn's disease
  4. Increased demand — pregnancy, lactation, growth spurts in children/adolescents
Clinical features explained:
  • Pallor: ↓ Hb → ↓ oxyhaemoglobin (pink colour) in skin, conjunctiva, mucous membranes
  • Weakness and fatigue: ↓ O₂ delivery to muscles → anaerobic metabolism → lactic acid → fatigue; also direct iron deficiency in mitochondrial enzymes
  • Respiratory distress: ↓ O₂-carrying capacity → tissue hypoxia → compensatory ↑ respiratory rate (hyperventilation) to maximize O₂ uptake

(b) Significance of MCV, MCH, and MCHC [2.5 marks]

MCV (Mean Corpuscular Volume):
  • Definition: Average volume of a single RBC
  • Calculation: MCV = Haematocrit (%) × 10 / RBC count (millions/µL) — unit: femtolitres (fL)
  • Normal: 80–100 fL
MCVInterpretationCauses
<80 fL (Microcytic)Small RBCsIron deficiency anaemia, thalassaemia, anaemia of chronic disease (sometimes), sideroblastic anaemia
80–100 fL (Normocytic)Normal RBCsAcute blood loss, haemolytic anaemia, anaemia of chronic disease, aplastic anaemia, renal failure
>100 fL (Macrocytic)Large RBCsVitamin B₁₂ deficiency, folate deficiency (megaloblastic), liver disease, hypothyroidism, alcoholism, reticulocytosis
Significance: MCV is the most useful index for classifying anaemia and guiding investigation.

MCH (Mean Corpuscular Haemoglobin):
  • Definition: Average weight/mass of Hb in a single RBC
  • Calculation: MCH = Hb (g/dL) × 10 / RBC count (millions/µL) — unit: picograms (pg)
  • Normal: 27–32 pg
MCHInterpretationCauses
<27 pg (Hypochromic)Low Hb per cellIDA, thalassaemia, sideroblastic anaemia
27–32 pg (Normochromic)NormalMost normocytic anaemias
>32 pg (Hyperchromic)High Hb per cellMegaloblastic anaemia, hereditary spherocytosis
Significance: MCH reflects Hb synthesis adequacy; useful alongside MCV to diagnose hypochromic microcytic anaemias. MCH correlates closely with MCV (a microcytic cell generally has less Hb).

MCHC (Mean Corpuscular Haemoglobin Concentration):
  • Definition: Average concentration of Hb per unit volume of RBCs (Hb density within cells)
  • Calculation: MCHC = Hb (g/dL) × 100 / Haematocrit (%) — unit: g/dL or %
  • Normal: 32–36 g/dL
MCHCInterpretationCauses
<32 g/dL (Hypochromic)Dilute Hb in cellsIDA, thalassaemia
32–36 g/dL (Normochromic)NormalNormocytic anaemias
>36 g/dL (Hyperchromic)Dense Hb in cellsHereditary spherocytosis (only true hyperchromic); also appears elevated in lipemic samples or cold agglutinins (artefactual)
Significance:
  • MCHC is the most reliable of the three indices (least affected by cell size)
  • Most sensitive indicator of IDA — MCHC falls last as iron stores deplete
  • Hereditary spherocytosis is the classic cause of elevated MCHC (spherocytes have less membrane surface relative to volume → concentrated Hb)
  • Used with MCV and MCH to complete the morphological classification of anaemia
  • Quality control marker: An MCHC >38 g/dL usually indicates a laboratory error or haemolysis

Question 7 — Cell Membrane Transport

Classify Cell Membrane Transport with Examples [2.5 marks]

CELL MEMBRANE TRANSPORT
         │
    ─────┴─────────────────────────
    │                             │
PASSIVE TRANSPORT            ACTIVE TRANSPORT
(No energy required;         (Energy required;
 down concentration          against concentration
 gradient)                   gradient)
    │                             │
    ├─ Simple Diffusion       ─── Primary Active Transport
    │   e.g. O₂, CO₂,             e.g. Na⁺/K⁺-ATPase,
    │   lipid-soluble drugs,       Ca²⁺-ATPase (SERCA),
    │   ethanol, urea              H⁺/K⁺-ATPase (stomach)
    │
    ├─ Facilitated Diffusion  ─── Secondary Active Transport
    │   (carrier or channel)       │
    │   e.g. GLUT1 (glucose),      ├─ Co-transport (Symport)
    │   AQP (water-aquaporin),     │   e.g. SGLT1/2 (Na⁺-glucose),
    │   ion channels               │   NKCC2 (Na⁺-K⁺-2Cl⁻)
    │                              │
    └─ Osmosis                     └─ Counter-transport (Antiport)
        (water movement                e.g. Na⁺/H⁺ exchanger (NHE3),
         via AQP or lipid)             Na⁺/Ca²⁺ exchanger (NCX)

VESICULAR TRANSPORT
    │
    ├─ Endocytosis (into cell)
    │   ├─ Phagocytosis (large particles; e.g. bacteria by macrophages)
    │   ├─ Pinocytosis (fluid; "cell drinking")
    │   └─ Receptor-mediated endocytosis (e.g. LDL receptor, transferrin)
    │
    └─ Exocytosis (out of cell)
        e.g. neurotransmitter release, insulin secretion, mucus secretion

Properties of Primary Active Transport [2.5 marks]

Primary active transport uses ATP directly (ATPase enzymes) to move substances against their electrochemical gradient:
  1. Energy source: Directly uses ATP hydrolysis (ATP → ADP + Pᵢ + energy) — hence "primary"
  2. Direction: Always moves ions against their electrochemical gradient (uphill transport)
  3. Carrier protein: Requires a specific ATPase pump protein (e.g., Na⁺/K⁺-ATPase, Ca²⁺-ATPase, H⁺/K⁺-ATPase)
  4. Specificity: Highly specific — each pump transports only specific ion(s)
  5. Saturable: Has a maximum transport rate (Tmax) when all pump molecules are occupied
  6. Inhibitable: Blocked by specific inhibitors:
    • Na⁺/K⁺-ATPase: Ouabain, digoxin (cardiac glycosides)
    • H⁺/K⁺-ATPase: Proton pump inhibitors (omeprazole)
    • Ca²⁺-ATPase: Thapsigargin
  7. Electrogenic: Na⁺/K⁺-ATPase transports 3 Na⁺ out and 2 K⁺ in → net export of one positive charge → contributes to negative RMP
  8. Temperature-dependent: Rate decreases at low temperatures (enzyme activity ↓)
  9. Regulated: Activity modulated by:
    • Intracellular Na⁺ concentration (↑ intracellular Na⁺ → ↑ pump activity)
    • Aldosterone (↑ Na⁺/K⁺-ATPase synthesis in collecting duct)
    • Thyroid hormones (↑ pump number → ↑ BMR)
  10. Ubiquitous: Na⁺/K⁺-ATPase present in virtually every cell; accounts for 20–40% of resting cellular energy expenditure
Examples:
  • Na⁺/K⁺-ATPase: 3 Na⁺ out, 2 K⁺ in (most important)
  • Ca²⁺-ATPase (SERCA): Ca²⁺ into SR/ER; Ca²⁺ out of cell (plasma membrane Ca²⁺-ATPase, PMCA)
  • H⁺/K⁺-ATPase: H⁺ out of parietal cell → gastric acid secretion
  • H⁺-ATPase: H⁺ secretion in renal collecting duct (type A intercalated cells)

Significance of Na⁺-K⁺ Pump [2.5 marks]

The Na⁺/K⁺-ATPase (sodium-potassium pump) is arguably the most important membrane protein in human physiology:
1. Maintenance of RMP:
  • Maintains the concentration gradients (high intracellular K⁺, high extracellular Na⁺) that generate the resting membrane potential (–70 mV)
  • Direct electrogenic contribution (3 Na⁺ out, 2 K⁺ in) ≈ –3 to –4 mV
  • Without it: gradients dissipate → RMP collapses → cells depolarize → loss of excitability
2. Regulation of Cell Volume:
  • Prevents osmotic swelling (see below)
3. Secondary Active Transport:
  • The Na⁺ gradient created by the pump drives co-transporters and exchangers (SGLT, NHE3, NKCC2, etc.) — Na⁺ entry coupled to glucose, amino acid, Ca²⁺ transport
  • All secondary active transport is indirectly powered by the Na⁺/K⁺-ATPase
4. Renal Na⁺ Reabsorption:
  • Na⁺/K⁺-ATPase on basolateral membrane of renal tubular cells → creates low intracellular Na⁺ → drives Na⁺ entry from tubular lumen → responsible for >99% of Na⁺ reabsorption → blood pressure and volume regulation
5. Intestinal Absorption:
  • Drives glucose and amino acid absorption from gut (via SGLT1 and Na⁺-amino acid cotransporters)
6. Cardiac Glycoside Target:
  • Digoxin inhibits the pump → ↑ intracellular Na⁺ → ↓ Na⁺/Ca²⁺ exchange → ↑ intracellular Ca²⁺ → ↑ cardiac contractility (positive inotropy) — basis of digitalis therapy
7. Heat Production:
  • Accounts for ~20–40% of basal metabolic rate heat production — important in thermogenesis
  • Thyroid hormones upregulate pump → ↑ BMR
8. Nerve and Muscle Excitability:
  • Restores ion gradients after action potentials — essential for repeated firing of neurons and muscle contraction
9. Acid-Base Balance:
  • Na⁺/H⁺ exchanger (driven by Na⁺ gradient) mediates H⁺ secretion in kidney → HCO₃⁻ reabsorption → acid-base regulation

How Na⁺-K⁺ Pump Maintains Cell Volume [2.5 marks]

Without the Na⁺/K⁺-ATPase, cells would swell and lyse. The pump prevents this through the following mechanism:
The Problem — Osmotic Swelling Tendency:
  1. Cells contain large amounts of impermeant intracellular solutes (proteins, organic phosphates, large anions) that cannot leave the cell
  2. These create an intracellular osmotic pressure that would continuously attract water into the cell → cell swelling → lysis
  3. Additionally, Na⁺ continuously leaks inward (down gradient) → ↑ intracellular osmolarity → osmotic water entry
How the Pump Prevents Swelling (Double Donnan Effect / Pump-Leak Model):
  1. Na⁺ pumping (3 Na⁺ out per cycle):
    • Continuously extrudes the Na⁺ that leaks in
    • Na⁺ is kept extracellular → Na⁺ acts as an "excluded osmole" — it is osmotically active outside but effectively excluded from inside
    • This counteracts the osmotic effect of intracellular impermeant anions
  2. Net solute extrusion:
    • 3 Na⁺ pumped out vs. 2 K⁺ pumped in = net loss of 1 osmole per cycle from cell
    • Intracellular osmolarity is maintained equal to extracellular (isotonic)
    • Water has no net osmotic driving force → cell volume is stable
  3. Electrogenic effect:
    • Net export of positive charge → inside negative → K⁺ (positive) is held inside by electrical gradient
    • This reduces effective intracellular K⁺ osmolarity (K⁺ is electrostatically "captured" — not free to exert full osmotic effect)
Evidence:
  • Ouabain (pump inhibitor): Cells swell progressively → cellular oedema → cell death
  • Metabolic poisoning (↓ ATP): Same result — pump fails → cell swells
  • Cold (4°C): Pump slows → slow swelling; warming restores volume
In summary: The Na⁺/K⁺-ATPase continuously pumps out more osmoles than it pumps in (3 out, 2 in), maintains Na⁺ outside as an osmotic counterforce to intracellular fixed anions, and thereby keeps intracellular osmolarity equal to extracellular → no net water movement → stable cell volume.

Question 7 (OR) — Coagulation

Definition of Clot & Fate of Clot [2.5 marks]

Definition of Clot (Thrombus): A blood clot is a semi-solid gelatinous mass formed at a site of vascular injury, consisting of a meshwork of fibrin strands in which platelets, RBCs, WBCs, and plasma proteins are entrapped. It is the end product of the coagulation cascade, formed to seal the vascular breach and arrest bleeding (haemostasis).

Fate of the Clot:
After a clot has served its haemostatic purpose, it undergoes the following:
1. Clot Retraction (within 20–60 minutes):
  • Platelets within the clot contain thrombosthenin (actomyosin-like contractile protein)
  • Platelets contract → pull fibrin strands together → clot shrinks and becomes denser/firmer
  • Serum (plasma minus fibrinogen/clotting factors) is squeezed out
  • Brings wound edges closer together → strengthens the seal
2. Organization (Days to Weeks):
  • Fibroblasts and endothelial cells from surrounding tissue invade the clot
  • Fibroblasts deposit collagen → clot replaced by fibrous tissue (scar)
  • In larger vessels: organized clot may partially or fully occlude the lumen (thrombus)
3. Fibrinolysis (Dissolution) — Most important fate:
  • Plasminogen (inactive) bound within the clot is activated to plasmin by:
    • t-PA (tissue plasminogen activator — from endothelial cells) — most important
    • u-PA (urokinase-type plasminogen activator)
    • Streptokinase (bacterial), staphylokinase
  • Plasmin cleaves fibrinFibrin Degradation Products (FDPs) including D-dimers
  • Clot gradually dissolves → vascular patency restored
  • Therapeutic use: t-PA, streptokinase, alteplase used in MI, stroke, PE to lyse clots
4. Recanalization:
  • In larger vessel thrombi: channels may form through the organized clot → partial restoration of blood flow
5. Embolization (Pathological):
  • If clot is not properly anchored or is too large → breaks off → embolus → travels to lung (PE), brain (stroke), or other organs

Basic Steps of Coagulation [2.5 marks]

Coagulation is a cascade of enzymatic reactions where inactive zymogens are sequentially activated, culminating in fibrin clot formation. It proceeds via two pathways converging on a common pathway:
I. Extrinsic Pathway (Tissue Factor Pathway — faster, 15 sec):
  1. Vascular injury → subendothelial Tissue Factor (TF/Factor III) exposed
  2. TF binds circulating Factor VII → forms TF-VIIa complex
  3. TF-VIIa complex activates Factor X → Xa (and also Factor IX → IXa)
II. Intrinsic Pathway (Contact Activation Pathway — slower, minutes):
  1. Exposed collagen activates Factor XII → XIIa (contact activation; also prekallikrein, HMWK)
  2. XIIa activates Factor XI → XIa
  3. XIa activates Factor IX → IXa
  4. IXa + Factor VIIIa (co-factor) + Ca²⁺ + phospholipid (on platelet surface) = "Tenase complex" → activates Factor X → Xa
III. Common Pathway: 5. Factor Xa + Factor Va (co-factor) + Ca²⁺ + phospholipid = "Prothrombinase complex" 6. Prothrombinase converts Prothrombin (Factor II) → Thrombin (Factor IIa) 7. Thrombin (key enzyme of coagulation):
  • Cleaves Fibrinogen (Factor I) → Fibrin monomers
  • Fibrin monomers polymerize → loose fibrin polymer (soluble)
  • Thrombin activates Factor XIII → XIIIa (transglutaminase)
  • Factor XIIIa cross-links fibrin → stable, insoluble fibrin polymer (clot)
  1. Thrombin also activates Factors V, VIII, XI (positive feedback amplification) and platelets
EXTRINSIC           INTRINSIC
Injury → TF        XII → XIIa
TF + VII → VIIa    XI  → XIa
          ↓         IX → IXa
         X ← ─────────── IXa + VIIIa (Tenase)
         ↓
        Xa + Va (Prothrombinase)
         ↓
   Prothrombin → THROMBIN
         ↓
   Fibrinogen → Fibrin monomer → [XIIIa] → Cross-linked FIBRIN CLOT
Co-factors required: Ca²⁺ (Factor IV) — required for Factors II, VII, IX, X binding to phospholipid surface via γ-carboxylation (Vitamin K-dependent: II, VII, IX, X, Protein C, Protein S).

Why Coagulation is Called a Positive Feedback Mechanism [2.5 marks]

Positive feedback means the product of a reaction amplifies and accelerates its own production — the reaction progressively intensifies rather than being self-limiting.
Coagulation is an ideal example of a positive feedback cascade for the following reasons:
1. Thrombin amplifies its own generation:
  • Thrombin (the key product) activates its own upstream co-factors:
    • Thrombin activates Factor V → Factor Va (accelerates prothrombinase complex → more thrombin)
    • Thrombin activates Factor VIII → Factor VIIIa (accelerates tenase complex → more Factor Xa → more thrombin)
    • Thrombin activates Factor XI → XIa → more Factor IXa → more Xa → more thrombin
  • Result: A small initial trigger → exponential amplification → massive thrombin burst
2. Platelet activation amplification:
  • Thrombin activates platelets → activated platelets release ADP, TXA₂ → recruit and activate more platelets → more phospholipid surface for coagulation → more thrombin generation
3. Factor XII auto-activation:
  • Factor XIIa activates more Factor XII → self-perpetuating contact activation
4. Cascade structure:
  • Each step activates the next and feeds back to amplify earlier steps
  • A tiny amount of initial Factor Xa or thrombin triggers increasingly large amounts of downstream product
Net result: This positive feedback ensures that once coagulation is initiated, it proceeds rapidly and completely to form a firm clot — essential for effective haemostasis where speed is critical.
Physiological check: Positive feedback is kept localised by natural anticoagulants (antithrombin III, protein C/S, TFPI) which prevent runaway systemic clotting.

Why Blood Does Not Clot Inside the Cardiovascular System [2.5 marks]

Despite all clotting factors circulating in blood, clotting normally does not occur inside intact vessels due to multiple protective mechanisms:
1. Smooth Endothelial Surface:
  • Intact endothelium is perfectly smooth → platelets do not adhere (no subendothelial collagen or TF exposed)
  • No contact activation of Factor XII
  • Physical smoothness prevents turbulence-induced activation
2. Prostacyclin (PGI₂) from Endothelium:
  • Endothelial cells constitutively synthesize prostacyclin (PGI₂) via cyclooxygenase
  • PGI₂ → ↑ cAMP in platelets → potent platelet aggregation inhibitor and vasodilator
  • Counteracts thromboxane A₂
3. Nitric Oxide (NO) from Endothelium:
  • Endothelial NOS (eNOS) constitutively produces NO
  • NO → ↑ cGMP in platelets → inhibits platelet activation and aggregation
  • Also causes vasodilation
4. Thrombomodulin — Protein C/S System:
  • Endothelial cells express thrombomodulin on their surface
  • Thrombomodulin binds thrombin → thrombin-thrombomodulin complex activates Protein C
  • Activated Protein C + Protein S (cofactor) → degrades Factor Va and Factor VIIIa → ↓ thrombin generation
  • Converts thrombin from pro-coagulant to anticoagulant
5. Antithrombin III (ATIII):
  • Plasma serine protease inhibitor (serpin)
  • Continuously inactivates thrombin, Factors IXa, Xa, XIa, XIIa
  • Action is enormously enhanced (1000×) by heparan sulphate on endothelial surface (endogenous heparin-like molecules)
  • Basis of therapeutic heparin action
6. Tissue Factor Pathway Inhibitor (TFPI):
  • Released by endothelium
  • Inhibits TF-VIIa complex and Factor Xa → blocks extrinsic pathway initiation
7. Fibrinolytic System:
  • Endothelium releases t-PA → converts plasminogen → plasmin → dissolves any microthrombi that form
8. Blood Flow (Laminar Flow):
  • Continuous flowing blood dilutes and washes away any activated clotting factors before they can accumulate to critical concentrations
  • Carries activated factors to liver for degradation
  • Prevents local concentration required for clot initiation
9. Liver Clearance:
  • Liver removes activated clotting factors, thrombin-antithrombin complexes from circulation
10. Negative surface charge:
  • Normal endothelium carries negative surface charge → repels negatively charged platelets → prevents adhesion
Summary Table:
MechanismWhat it prevents
Smooth endotheliumContact activation, platelet adhesion
PGI₂ / NOPlatelet aggregation
Thrombomodulin/Protein C/SThrombin amplification (↓ Va, VIIIa)
Antithrombin III + heparan sulphateThrombin and factor inactivation
TFPIExtrinsic pathway
t-PA / fibrinolysisMicrothrombus dissolution
Blood flowFactor dilution and washout

Answers based on Guyton & Hall Medical Physiology (14th ed.), Ganong's Review of Medical Physiology (26th ed.), and Lippincott's Illustrated Reviews: Biochemistry.
This is a shared conversation. Sign in to Orris to start your own chat.